| Name | Research_Grant_Category | start_year | end_year | granting_agency | title | principal_investigator | co_principal_investigators | amount_per_year |
|---|---|---|---|---|---|---|---|---|
| Agatha Jassem | Operating Grant | 2020 | 2021 | Public Health Agency of Canada | Occupational Risk Posed By SARS-CoV-2 to Teachers | Pascal Lavoie | David Goldfarb, Brian Grunau, Genelle Haeley, Agatha Jassem, Mohammed Morshed, Ralph Pantophlet, Steven Pelech, Inna Sekirov, Bruce Vallance | 500,000 |
| Agatha Jassem | Operating Grant | 2021 | 2021 | Genome British Columbia | COVID-19 Sequencing and Modelling Integrated with Laboratory and Epidemiological Sources (SMILES) | Agatha Jassem, Natalie Prystajecky, Caroline Colijn | Hind Shibi, Chris Fjell, Naveed Janjua, John Tyson, Paul Levett, Paul Tupper, Danuta Skowronski | 200,000 |
| Agatha Jassem | Operating Grant | 2020 | 2021 | Public Health Agency of Canada | COVID-19 Occupational Risks, Seroprevalence and Immunity among Paramedics in Canada | Brian Grunau | Tracy Kirkham, Paul Demers, David Goldfarb, Vilte Barakauskas, Sheldon Cheskes, James Christenson, Ian Drennan, Jocelyn Srigley, Agatha Jassem, Jennie Helmer, Richard Armour, Sandra Jenneson | 500,000 |
| Agatha Jassem | Operating Grant | 2020 | 2021 | Michael Smith Foundation for Health Research | Quantitative isotype profiling and dynamics of SARS-CoV-2 infections: Next-generation serology | Mari DeMarco | Agatha Jassem | 124,000 |
| Agatha Jassem | Operating Grant | 2020 | 2021 | CIHR | COVID-19 household study to assess secondary attack rates and the proportion asymptomatic, including children | Cecile Tremblay | Danuta Skowronski, Gaston De Serres, Guy Boivin, Inna Sekirov, Linda Hoang, Manish Sadarangani, Mayank Singal, Mel Krajden, Morshed Muhammad, Natalie Prystajecky, Soren Gantt, Agatha Jassem | 864,570 |
| Agatha Jassem | Operating Grant | 2020 | 2021 | CIHR | Household transmission of SARS-CoV-2 in a well-characterized African cohort | Soren Gantt | Dawn McArthur, Manish Sadarangani, Mike Irvine, Richard Harrigan, Agatha Jassem | 450,635 |
| Agatha Jassem | Operating Grant | 2020 | 2021 | Michael Smith Foundation for Health Research | Population-based study of coronavirus antibody cross-reactivity to inform SARS-CoV-2 seroprevalence surveys, severity profiles, and vaccine strategies | Agatha Jassem | Danuta Skowronski, Inna Sekirov, Soren Gantt, Will Hsiao | 150,000 |
| Agatha Jassem | Operating Grant | 2021 | 2022 | CIHR | Teasing apart the differential impact of variants of concern on COVID-19 severity and health inequities: a population-based genomic epidemiological investigation in Ontario and British Columbia | Hind Sbihi, Naveed Janjua, Beate Sander, Catherine Hogan, Jeffrey Kwong, Michael Irvine, Sharmistha Mishra | Y. Abdia, N. Daneman, A. Jassem, M. Murti, I. Sekirov, H. Velásquez García, S. Baral, E. Galanis, M. Krajden, S. Patel, E. Smolina, K. Brown, J. Gubbay, R. Kustra, N. Prystajecky, J. Tyson, S. Buchan, L. Hoang, S. Mubareka, C. Rose, T. Vanniyasingam | 451,188 |
| Agatha Jassem | Operating Grant | 2020 | 2023 | CIHR | Role of early childhood viral infection on the development of childhood sleep disordered breathing | Agatha Jassem, Piush Mandhane | C. Burton, S. Hanna, T. Moraes, W. Hsiao | 562,276 |
| Agatha Jassem | Operating Grant | 2021 | 2023 | PHAC | The PREVENT-COVID Study: PRospEctiVe EvaluatioN of immuniTy after COVID-19 vaccines | Agatha Jassem, Manish Sadarangani | Inna Sekirov, Muhammad Morshed, Mel Krajden, Danuta Skowronski, James Zlosnik, Sofia Bartlett, Citlali Marquez | 1,930,602 |
| Agatha Jassem | Operating Grant | 2020 | 2023 | CIHR | Predicting and Evaluating Anal Cancer in HIV with novel biomarkers: The PEACH Study | Jonathan Grennan, Ann Burchell, Irving Salit | Joshua Edward, Mark Gaspar, Jennifer Gillis, Daniel Grace, Ramandip Grewal, Mark Hull, Paul MacPherson, Ronita Nath, Gina Ogilvie, Ron Rosenes, Darrell Tan, Edward Weiss, Malcolm Hedgecock, Jody Jollimore, Agatha Jassem, Mel Krajden, Tyler Morden, Janet Raboud | 1,200,000 |
| Agatha Jassem | Operating Grant | 2020 | 2025 | CFI | Linking Transmission Metadata to Viral Genotype and Serological Response of COVID-19 | Mel Krajden | Anders Goncalves da Silva, Agatha Jassem, Natalie Prystajecky, Inna Sekirov | 620,000 |
| Ali Bashashati | Operating Grant | 2019 | 2021 | Carraresi Foundation (Merit-based) | Artificial Intelligence for Precision Medicine in Endometrial Carcinoma | Ali Bashashati | David Farnel | 20,000 |
| Ali Bashashati | Operating Grant | 2019 | 2021 | UBC School of Biomedical Engineering, Collaborative Seed Grant | Spatial mapping of single cell RNA-seq and quantification of heterogeneity in multiple tumor types | Ali Bashashati | Michael Underhill | 100,000 |
| Ali Bashashati | Operating Grant | 2020 | 2021 | Cascadia Data Alliance | Pathology AI for a Federated Quality Assurance Program: Ovarian Cancer Pilot | David Huntsman Ali Bashashati Blake Gilks Holly Harris Terry Morgan Ivan Beschastnikh Aline Talhouk | Co-applicants: Steven Jones Charles W. Drescher Tania Bubela Jean-Francois Rajotte | 561,183 |
| Ali Bashashati | Operating Grant | 2020 | 2021 | UBC Faculty of Medicine Strategic Investment Fund (SIF) | BC Translational Digital Pathology & AI Initiative | Ali Bashashati | 100,000 | |
| Ali Bashashati | Operating Grant | 2019 | 2022 | Canadian Institute for Health Research (CIHR) | Omics, histopathology and AI: an integrative approach for biomarker discovery in ovarian cancer | Ali Bashashati (NPI) Blake Gilks Tim Salcudean | Co-applicants: David Huntsman Purang Abolmaesumi Michael Anglesio Aline Talhouk | 822,376 |
| Ali Bashashati | Operating Grant | 2020 | 2022 | Canadian Cancer Society Research Institute (CCSRI) | p53 abnormal endometrial carcinomas: the most lethal and aggressive uterine cancer | Jessica McAlpine | co-Applicants: Ali Bashashati David Huntsman Blake Gilks Aline Talhouk Lynn Hoang | 180,000 |
| Ali Bashashati | Operating Grant | 2021 | 2022 | UBC Strategic Investment Fund | Molecular and Advanced Pathology Core (MAPcore): a Translational Research Core Platform for UBC | David Huntsman | co-investigators: Ali Bashashati, Michael Anglesio, Samuel Aparicio, Blake Gilks, Lynn Hoang, Amal El Naggar, Torsten Nielsen, Tony Ng, David Schaeffer, Poul Sorensen, Aline Talhouk, Emily Thompson, Stephen Yip | 160,000 |
| Ali Bashashati | Infrastructure Grant | 2021 | 2023 | Canadian Foundation for Innovation (CFI), JELF Program | AI-driven platform for translating precision medicine discoveries in women’s cancers | Ali Bashashati | Aline Talhouk (co-investigator) | 325,000 |
| Ali Bashashati | Infrastructure Grant | 2021 | 2023 | BC Knowledge Development Fund (BCKDF) | AI-driven platform for translating precision medicine discoveries in women’s cancers | Ali Bashashati | Aline Talhouk (co-investigator) | 325,000 |
| Ali Bashashati | Operating Grant | 2019 | 2024 | Natural Sciences & Engineering Research Council of Canada (NSERC) | Deep learning framework for the accurate detection of DNA changes from high throughput sequencing data | Ali Bashashati | 152,500 | |
| Ali Bashashati | Operating Grant | 2021 | 2026 | Canadian Institute for Health Research (CIHR) | Prostate cancer risk stratification for active surveillance using computer-aided analysis of histopathology and transcriptomics | Ali Bashashati (NPI) | Larry Goldenberg Peter Black Tim Salcudean Co-applicants: Martin Gleave Daniel Lin | 906,525 |
| Ali Bashashati | Salary Support | 2021 | 2026 | Michael Smith Foundation for Health Research (MSFHR) | AI-driven integration of omics and histopathology for biomarker discovery in cancer | Ali Bashashati | 450,000 | |
| Ali Bashashati | Operating Grant | 2021 | 2026 | Canadian Institute for Health Research (CIHR) | Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colorectal Cancer: A Multicentre Phase II/III Randomised Controlled Trial (DYNAMIC-III) | Jonathan Loree, Christopher O'Callaghan | Ali Bashashati (Co-Investigator), David Schaeffer, and 10+ more investigators | 1,426,724 |
| Allison Matthews | Other (development grants) Grant | 2019 | Present | BCCHRI- Childhood Disease Next Step Grant | Clinical Validation of Next Generation Sequencing | Dr Tanya Nelson | Co-Leads: Dr Lindsay Brown & Dr Christine Tyson Co-applicants: Dr Bradley Coe & Dr Allison Matthews | ~$25,000 |
| Aly Karsan | Operating Grant | 2016 | 2021 | Canada Foundation for Innovation | Canadian Distributed Cyber-Infrastructure for Genomics | M Brudno (NPI), T Basik, G Bourque, PE Jacques, Y Joly, S Jones, A Karsan, M Lathrop, T Pugh, S Scherer, C Virtanen | $3,920,000 | |
| Aly Karsan | Operating Grant | 2019 | 2021 | AstraZeneca | An evaluation of BRCA tumour testing for ovarian cancer in British Columbia | A Karsan | P Hoskins, A Tinker, J Kwon, K Schrader, S Sun | $224,000 |
| Aly Karsan | Operating Grant | 2019 | 2021 | BC Cancer Foundation | Male Breast Cancer Access Plan to the Hereditary Cancer Program | K Schrader, S Sun, A Karsan, | M Thibodeau, D Regier | $75,000 |
| Aly Karsan | Operating Grant | 2016 | 2022 | Canadian Institutes of Health Research/ Natural Sciences and Engineering Research Council | Development of an automated end-to-end next generation sequencing assay to detect all classes of genetic variant in a single diagnostic test | A Karsan (NPI), M Marra | E Ratnarajah, I Birol, R Moore, Y Zhao, R Coope, P Watson, H Kennecke, C Ho, I Bosdet, L Swanson | $906,304 |
| Aly Karsan | Operating Grant | 2017 | 2022 | Genome BC | Automation of the Clinical Bioinformatics Pipeline at the Centre for Clinical Genomics | A Karsan | I Birol, L Swanson, I Bosdet, H Jouet, TR Docking | 1,999,999 |
| Aly Karsan | Operating Grant | 2018 | 2022 | Canadian Institutes of Health Research | Early detection of cancer in high-risk patients through profiling of circulating tumour DNA | T Pugh, R Kim, A Pollet | A Karsan, S Jones, K Schrader, R Khokha | $1,977,525 |
| Aly Karsan | Operating Grant | 2018 | 2022 | Canadian Cancer Society Research Institute | Mechanisms of resistance to 5-Azacytidine | A Karsan | R Buckstein, M Hirst | $450,000 |
| Aly Karsan | Operating Grant | 2018 | 2022 | Genome Canada | Deciphering the genome biology of relapsed lymphoid cancers to improve patient management | C Steidl, M Marra, D Scott | A Karsan, J Connors, R Morin, D Regier, R Kridel | $11,926,360 |
| Aly Karsan | Operating Grant | 2018 | 2022 | Genome Canada | PEGASUS-2 - PErsonalized Genomics for prenatal Abnormalities Screening Using maternal blood: Towards First Tier Screening and Beyond | F Rousseau (Project Leader), S Langlois (Co-project leader) | A Karsan, D Reinharz, V Ravitsky, F Legare, B Wilson, C McCabe, JR Guertin, T Caulfield, AM Laberge, G Rouleau, JC Forest, J Little, F Audibert, J Michaud, A Giguere, RD Wilson, Y Giguere, L Wei, R Duncan, C Gagne, J Longtin, M Vallee, M Ouimet, M de Guise, J Evans, J Friedman, W McKellin, M Walker, M Pazzagli, E Pelo, J Vermeesch, M Vekemans, I Levesque, H Bekker | $12,241,630 |
| Aly Karsan | Operating Grant | 2019 | 2022 | The Leukemia and Lymphoma Society of Canada | Bypassing resistance to Lenalidomide in del(5q) MDS | A Karsan | $200,000 | |
| Aly Karsan | Operating Grant | 2020 | 2022 | BC Cancer Foundation | Hereditary male breast cancer: characterization of known and novel familial predispositions using short and long reads sequencing technologies | S Jones | A Karsan, ML Thibodeau, S Sun, S Yip, J Laskin, M Marra | $74,891 |
| Aly Karsan | Team Grant | 2017 | 2024 | Terry Fox Research Institute | The Terry Fox New Frontiers Program Project Grant in Exploiting Pathogenic Mechanisms in Acute Leukemia for Clinical Translation | A Karsan (Program Lead), C Eaves, A Weng, M Hirst K Humphries | R Broady, P Lansdorp, G Morin, | $6,922,469 |
| Aly Karsan | Operating Grant | 2019 | 2026 | Canadian Institutes of Health Research | Vascular differentiation | A Karsan | $929,339 | |
| Aly Karsan | Operating Grant | 2019 | 2026 | Canadian Institutes for Health Research | Hematopoietic stem cell aging | A Karsan | $933,244 | |
| Andrew Churg | Operating Grant | 2020 | 2021 | Worker's Compensation Board of BC (WorkSafe BC) | Blood-based screening and personalized treatment of malignant mesothelioma | Collin Colins | Andrew Churg | $140,000 |
| Andrew Minchinton | Operating Grant | 2018 | 2021 | Canadian Institutes of Health Research (CIHR) in partnership with the Natural Sciences and Engineering Research Council of Canada (NSERC) | Hypoxia-selective inhibitors of DNA repair | A Minchinton | J Bacha, D Perrin | 518,762 |
| Andrew Minchinton | Operating Grant | 2018 | 2021 | Pfizer Canada Inc. | Development of small molecule DNA repair inhibitors | Andrew Minchinton | $200,000 | |
| Andrew Minchinton | Operating Grant | 2019 | 2021 | Michael Smith Foundation for Health Research (MSFHR) | DNAPK inhibitors for use in combination with radiation therapy | Andrew Minchinton | $150,000 | |
| Andrew Minchinton | Operating Grant | 2021 | 2021 | adMare | Clinical candidate selection - Development of systemically active inhibitors of DNA-PK | Andrew Minchinton | $500,000 | |
| Andrew Minchinton | Operating Grant | 2019 | 2022 | Canadian Institutes of Health Research | Hypoxia-activated DNA repair inhibitors to improve cancer therapy | Andrew Minchinton | $573,750 | |
| Andrew Roth | Operating Grant | 2018 | 2021 | University of British Columbia (Faculty of Science) | Institutional support | A. Roth | $75,000 | |
| Andrew Roth | Operating Grant | 2018 | 2021 | BC Cancer, part of the Provincial Services Health Authority | Institutional Funding Support | A. Roth | $300,000 | |
| Andrew Roth | Operating Grant | 2018 | 2021 | BC Cancer Foundation | Institutional Funding Support | A. Roth | $300,000 | |
| Andrew Roth | Operating Grant | 2021 | 2022 | Cascadia Data Alliance | Monitoring breast cancer: Bringing single-cell and liquid biopsy analysis to the cloud | Roth | Ha, Aparicio, Hunter | 280000 |
| Andrew Roth | Operating Grant | 2021 | 2023 | The Cancer Research Society | Metabolomic markers to target prevention of postmenopausal breast cancer among overweight and obese women. | Bhatti | Roth | 120,000 |
| Andrew Roth | Operating Grant | 2021 | 2024 | V Foundation for Cancer Research | Predicting Follicular Lymphoma Transformation from Tumour Architecture, Grant | Roth | 200,000 | |
| Andrew Roth | Salary Support | 2019 | 2024 | Michael Smith Foundation for Health Research | Development and Application of Computational Methods for Profiling Cancers at Single Cell Resolution | A. Roth | $450,000 | |
| Andrew Roth | Under Review | 2021 | 2026 | Natural Sciences and Engineering Research Council of Canada | Probabilistic Models for Single Cell Biology | Roth | 107,625 | |
| Andrew Roth | Under Review | 2021 | 2026 | Terry Fox Research Institute | Genomic and epigenomic sequencing to understand resistance and relapse in AML | Karsen | 12,811,865 | |
| Andrew Roth | Under Review | 2021 | 2026 | Department of Defense (USA) | From genesis to transformation: the search for targetable impacts of ARID1A loss in ovarian cancer. | Huntsman | Roth, Hoang | 600,000 |
| Andrew Roth | Under Review | 2022 | 2027 | Canadian Institutes of Health Research (CIHR) | Characterizing cell-cell interactions in human follicular lymphoma using primary tumor organoid cultures | Weng | Roth, Steidl, Scott | 1,250,000 |
| Andrew Roth | Under Review | 2022 | 2028 | European Research Council | PRImary tumour to MEtastasis — Clinically Aimed Spatial and Evolutionary studies | Jens Lagergren | Jamal Hanjani/McGranahan | 12,000,000 EUR |
| Andrew Roth | Under Review | 2022 | 2028 | European Research Council | Primary tumor to metastasis - Clinically aimed spatial and evolutionary studies | Jens Lagergren | Mariam Jamal-Hanjani Nicholas McGranahan | 1722000 Euro |
| Andrew Shih | Group Grant | 2020 | 2021 | Canadian Blood Services BloodTechNet Award Program | Blood and stem cell donation for men who have sex with men in Canada: A toolkit for healthcare professionals | Dr. Warren Fingrut | UBC Collaborators: Dr. Tanya Petraszko, Dr. Matthew Yan | 20000 |
| Andrew Shih | Operating Grant | 2020 | 2021 | Canadian Blood Services Blood Efficiency Accelerator Award Program | Demonstration of genetic blood group transition in patients undergoing ABO mismatched hematopoietic stem cell transplantation by peripheral blood quantitative polymerase chain reaction targeting the ABO locus | Dr. Andrew Shih | Dr. Eric McGinnis, Dr. Ryan Stubbins, Dr. Paul Keown, Dr. Lenka Allan, Dr. Michael Barnett, Dr. Monika Hudoba, Dr. Sujaatha Narayanan, Dr. Tanya Petraszko | 15990 |
| Andrew Shih | Operating Grant | 2019 | Present | University of British Columbia Division of Hematopathology Resident Research Grant | Determining Coagulopathy through ROTEM Coagulation Testing in Liver Disease | Dr. Andrew Shih | Dr. Tyler Smith Dr. Stephen Ho Dr. Muntadhar Al-Moosawi | 5000 |
| Andrew Shih | Operating Grant | 2019 | Present | University of British Columbia Division of Hematopathology Resident Research Grant | Frequency of Positive Antibody Screens on patients with Serial Group and Screens Every 3 Days (PASSeS 3D Study) | Dr. Andrew Shih | Dr. Bhupinder Johal Dr. Ann Tran Dr. Monika Hudoba | 5000 |
| Andrew Weng | Operating Grant | 2016 | 2021 | Canadian Institutes of Health Research (CIHR) | Mediators and targets of Wnt signaling in T-ALL stem cells | AP Weng | V Giambra | $168,190 |
| Andrew Weng | Operating Grant | 2016 | 2021 | Canadian Institutes of Health Research (CIHR) | Resolution of inter- and intra-tumoral heterogeneity in DLBCL using mass cytometry | AP Weng | RR Brinkman, CS Steidl | $172,013 |
| Andrew Weng | Team Grant | 2016 | 2021 | Terry Fox Research Institute (Terry Fox Foundation) | Overcoming Treatment Failure in Lymphoid Cancers (New Frontiers Program Project Grant) | J Connors | S Shah, C Steidl, AP Weng, D Scott | $183,422 (to APW) |
| Andrew Weng | Equipment Grant | 2021 | 2021 | Research Facility Support Grant (RFSG) | Spectral flow cytometer upgrade | AP Weng | 50000 | |
| Andrew Weng | Team Grant | 2017 | 2022 | Terry Fox Research Institute (Terry Fox Foundation) | Exploiting Pathogenic Mechanisms in Acute Leukemia for Clinical Translation (New Frontiers Program Project Grant) | A Karsan | AP Weng, C Eaves, K Humphries M Hirst, R Broady, P Lansdorp, G Morin | $231,335 (to APW) |
| Andrew Weng | Operating Grant | 2020 | 2022 | Canadian Institutes of Health Research (CIHR) | Machine Learning for Flow Cytometry Clinical Data and Trial Analysis | RR Brinkman | $173,168 | |
| Anna Fong Lee | Operating Grant | 2018 | 2022 | Canadian Institutes of Health Resesarch | Sexual pain in endometriosis: role of somatic mutations and local neurogenesis | Anglesio, Michael; Gilks, C. Blake; Howard, Amanda F.; Mohamed, Ali Bedaiwy; Yong, Paul | 976,904 | |
| Basil Horst | Operating Grant | 2019 | 2021 | NIH, National Cancer Institute; UH2 | A prognostic mRNA immune signature for resected stage II-III melanoma | Saenger | Horst | 160000 /yr |
| Basil Horst | Under Review | 2021 | 2026 | NIH/National Cancer Institute | Applying pathomics to establish a biosignature for aggressive skin melanoma (Pending) | Saenger | Horst | 250000 /yr |
| Bojana Rakic | Operating Grant | 2019 | 2021 | BCHRI CRSU Clinical Research Support | Next generation urine metabolic profiling for the diagnosis and monitoring of inborn errors of metabolism | Bojana Rakic | 25000 | |
| Bojana Rakic | Operating Grant | 2018 | Present | BCCHR BioBank | Investigating Tm-cell function in frozen peripheral blood mononuclear cells from BioBank samples-proof of concept experiments | Bojana Rakic | Graham Sinclair | 5000 |
| Bojana Rakic | Operating Grant | 2020 | Present | Ethics Application H19-02106 | FAO T cell study Study approved by full board and request for Stage 2 resumption of research by BCCHR Institute was granted | Bojana Rakic | Ramon Klein Geltink, Graham Sinclair, Megan Levings, Sylvia Stockler | |
| Bruce McManus | Other (education innovation) Grant | 2018 | 2021 | The Heart & Stroke Foundation of Canada | Enterviral control of autophagy: Relevance to heart failure | Honglin Luo | Bruce McManus | 75750 |
| Bruce McManus | Other (development grants) Grant | 2017 | 2022 | Canada Foundation for Innovation (CFI) | TORCH (Towards Omics and Imaging to Revolutionize COPD and Asthma Health ) in Canada | Bruce McManus | 441262 | |
| Bruce McManus | Other (development grants) Grant | 2018 | 2023 | Canadian Institutes of Health Research (CIHR) | HEARTBiT: A novel multi-marker blood test for management of acute cardiac allograft rejections | Bruce McManus | 436050 | |
| Bruce Verchere | Team Grant | 2019 | 2021 | UBC VP Research & Innovation office | BC Diabetes Research Network | Bruce Verchere | many other UBC investigators | 175,500 |
| Bruce Verchere | Operating Grant | 2019 | 2021 | JDRF | Validation of new prolAPP-derived T1D biomarkers | Verchere | Speake (Univ .of Washington) | $178,648 |
| Bruce Verchere | Operating Grant | 2019 | 2021 | Michael Smith Foundation for Health Research Innovation 2 Commercialization (I2C) | Novel nanomedicines resolving inflammation as a treatment for type 2 diabetes | Verchere | Cullis, Cuifolini | $150,000 |
| Bruce Verchere | Operating Grant | 2019 | 2021 | Nanomedicines Innovation Network (NMIN) National Centre of Excellence (NCE) | Targeting the NLRP3 inflammasome with lipid nanoparticles for the treatment of type 2 diabetes | Verchere | Cullis, Cuifolini | $99,500 |
| Bruce Verchere | Operating Grant | 2017 | 2022 | Canadian Institutes of Health Research | Genetic and acquired defects in islet prohormone processing in diabetes | Bruce Verchere | $180,540 | |
| Bruce Verchere | Operating Grant | 2020 | 2022 | Stem Cell Network (SCN) | Genetic manipulation of hES-derived insulin producing cells to improve graft outcomes | Verchere | Lynn, Levings, Kieffer | $292,000 |
| Bruce Verchere | Team Grant | 2020 | 2022 | BC Digital Technology Supercluster | Trustsphere | Amed | Multiple investigators and industry partners | TBD |
| Bruce Verchere | Team Grant | 2020 | 2023 | CIHR Human Immunology Team Grant | Levings | Verchere, Panagiotopoulos, Wherret (Toronto), Crome (Toronto) | $1,600,000 | |
| Bruce Verchere | Operating Grant | 2020 | 2025 | Canadian Institute of Health Research | Islet macrophages: regulators of beta cell function in health and diabetes | Bruce Verchere | $952,426 | |
| Bruce Verchere | Team Grant | 2021 | 2026 | CIHR-JDRF – Accelerating Stem Cell-Based Therapies for Type 1 Diabetes Team Grant | Generation of a functionally robust stem cell-based therapy for type 1 diabetes | Lynn | Verchere, Levings, Johnson, MacDonald (Alberta), Bruin (Carleton) | $6,000,000 |
| Calum MacAulay | Operating Grant | 2017 | 2022 | Canada Foundation for Innovation | TORCH (Towards Omics and Imaging to Revolutionize COPD and Asthma Health) In Canada | Sin D | Coxson H, DeMarco M, Hackett TL, Leipsic J, MacAulay C, McManus B, Ng R, Pare P, Walley K | $2,206,311 |
| Catherine Hogan | Operating Grant | 2019 | 2021 | BMGF Ragon/Stanford Collaborative Pilot Award | Sensitive and Noninvasive Diagnosis of Mycobacterium tuberculosis using CRISPR-Cas13a | Catherine Hogan | $100,000 | |
| Catherine Hogan | Training Grant | 2018 | 2022 | Canadian Institutes of Health Research Fellowship Grant | HIV/AIDS Priority Announcement | Role: Research trainee fellowship recipient | $240,000 | |
| Catherine Hogan | Operating Grant | 2021 | 2026 | Michael Smith Foundation for Health Research | Health Professional Investigator (HP-I) Award | Catherine Hogan | $450,000 | |
| Cheryl Wellington | Operating Grant | 2019 | 2021 | Vancouver Coastal Health Research Institute (VCHRI) Innovation and Translational Research Award | TAPping into concussion blood biomarkers: Feasibility Assessment of Touch Activated Phlebotomy (TAP) for youth concussion blood biomarker studies | Cheryl Wellington | Ian Pike; Shelina Babul | 75,000 |
| Cheryl Wellington | Operating Grant | 2019 | 2021 | Alzheimer Society of Canada | The role of smooth muscle cell metabolism of amyloid beta in cerebral amyloid angiopathy | Gordon Francis | Cheryl Wellington | 150,000 |
| Cheryl Wellington | Operating Grant | 2019 | 2021 | Pacific Alzheimer's Research Foundation | Precision genetic model of neurovascular unit to study Alzheimer Disease | Haakon Nygaard | Cheryl Wellington | 150,000 |
| Cheryl Wellington | Operating Grant | 2020 | 2021 | Canadian Institutes of Health Research (CIHR) | Using bioengineered human vessels to understand how brain and peripheral apoE affect cerebrovascular functions relevant to Alzheimer's Disease | Cheryl Wellington | Jerome Robert | 100,000 |
| Cheryl Wellington | Operating Grant | 2019 | 2021 | UBC School of Biomedical Engineering | Neurovascular unit on a chip to study Alzheimer's disease | Cheryl Wellington | Karen Cheung | 100,000 |
| Cheryl Wellington | Operating Grant | 2017 | 2022 | Canadian Foundation for Innovation Innovation Fund | Multimodal development of the CHIMERA platform of traumatic brain injury | Cheryl Wellington | David Lampron; Ian Welch; Peter Cripton; Piotr Kozlowski; Ryan; Brinkman; Sara Mostafavi; Tim Salcudean; William Panenka; Wolfram Tetzlaff | 11,375,233 |
| Cheryl Wellington | Operating Grant | 2019 | 2022 | International Collaboration on Repair Discoveries | Translating Neurochemical Biomarkers from Traumatic Brain Injury to Acute Spinal Cord Injury | Cheryl Wellington | Brian Kwon | 20,000 |
| Cheryl Wellington | Operating Grant | 2019 | 2022 | National Football League Play Smart Play Safe | Surveillance in High Schools to Reduce Concussions in Youth: SHRed Concussions | Carolyn Emery | Cheryl Wellington, Bradley Goodyear; Ian Pike; Kathryn Schneider; Nick Reed; Pierre Fremont; Shelina Babul | 9,438,473 US |
| Cheryl Wellington | Operating Grant | 2020 | 2023 | Department of Defense (USA) | Using the CHIMERA model to dissect the mechanisms by which Abeta modulates chronic feat memory extinction and cognitive flexibility after Traumatic Brain Injury | Cheryl Wellington | Mark Cembrowski | 500,000 US |
| Cheryl Wellington | Operating Grant | 2020 | 2023 | Weston Brain Institute Transformational | Using the CHIMERA (Closed Head Impact Model of Engineered Rotational Acceleration) model of Traumatic Brain Injury to evaluate the efficacy of compounds for tau, A-beta and apoE to attenuate trauma-induced increased risk of neurodegeneration | Cheryl Wellington | David Vocal; Haakon Nygaard; Neil Cashman | 1,500,000 |
| Cheryl Wellington | Operating Grant | 2019 | 2024 | National Institutes of Health (NIH) (USA) | Clinical validation of serum neurofilament light as a biomarker of traumatic axonal injury (Total $520,972 to Wellington lab) | Ramon Diaz-Arrastia | Ava Puccio; Pashtun Shaim; Pratik Mukherjee | 3,683,873 US |
| Cheryl Wellington | Operating Grant | 2019 | 2024 | Department of Women and Gender Equality | Generating and translating knowledge on intimate partner violence and traumatic brain injury | Paul van Donkelaar | Heather Gainforth; Shelina Babul; William Panenka | 1,000,000 |
| Cheryl Wellington | Operating Grant | 2021 | 2024 | Weston Brain Institute | Neurological Outcomes of COVID-19 Patients | Cheryl Wellington | Jonathan Stoessl; Nicholas Fergusson; Noah Silverberg; Ryan Hoiland; Sophie Stukas; Thalia Field; William Honer, Mypinder Sekhon, William Panenka | 1,500,000 |
| Cheryl Wellington | Operating Grant | 2020 | 2025 | Canadian Institutes of Health Research (CIHR) Network Catalyst | Canadian Concussion Network | Keith Yeates | Anne Wheeler; Carolyn Emery; Isabelle Gagnon; Kathryn Schneider; Pierre Fremont; Roger Zemek | 1,000,000 |
| Cheryl Wellington | Operating Grant | 2021 | 2025 | CIHR | Evaluating the potential of blood biomarkers to improve Alzheimer's Disease risk stratification | Cheryl Wellington | Angela Brooks-Wilson; Howard Chertkow; Robin Hsiung; Roger Dixon; Collaborator: Khosrow Adeli | 1,503,224 |
| Christian Steidl | Operating Grant | 2016 | 2021 | National Cancer Institute | Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients | C. Steidl | $402,872 | |
| Christian Steidl | Operating Grant | 2016 | 2021 | Canadian Institutes of Health Research | Resolution of inter- and intra-tumoral heterogeneity in DLBCL using mass cytometry | A. Weng | C. Steidl, R. Brinkman | $860,064 |
| Christian Steidl | Operating Grant | 2016 | 2021 | Canadian Institutes of Health Research | The biology and clinical significance of the tumour microenvironment in B cell lymphomas | C. Steidl | G. Morin, M. Bally, K. Savage, S.Shah, A. Weng, G. Slack | $1,534,008 |
| Christian Steidl | Operating Grant | 2019 | 2021 | Leukemia and Lymphoma Society of Canada | PRAME alterations in DLBCL: Clinical and functional significance | C. Steidl | $200,000 | |
| Christian Steidl | Team Grant | 2016 | 2022 | Terry Fox Research Institute | Overcoming treatment failure in lymphoid cancers | C. Steidl | M. Marra, D. Scott, R. Morin, S. Shah, A. Weng, G. Morin, G. Slack, P. Farinha, C. Hansen | $7,500,000 |
| Christian Steidl | Operating Grant | 2018 | 2022 | Paul Allen Frontiers Group | The microenvironment architecture and ecosystem of Hodgkin lymphoma at single cell resolution | C. Steidl | A. Merchant | $1,500,000 |
| Christian Steidl | Team Grant | 2018 | 2024 | Genome Canada | Deciphering the genome biology of relapsed lymphoid cancers to improve patient management | C. Steidl | M. Marra, D. Scott, A. Karsan, D. Regier, R. Kridel, R. Morin, J. Connors, G. Slack, S. Kamel-Reid | $11,926,360 |
| Christian Steidl | Operating Grant | 2020 | 2025 | Canadian Institutes of Health Research (CIHR) | Mechanisms of B cell-mediated immunity in human cancer | B. Nelson | C. Steidl, G. Morin | $1,193,400 |
| Christian Steidl | Team Grant | 2021 | 2026 | Canada Foundation for Innovation-The ExCELLirate Canada | ExCELLirate Canada: Expanding CELL-based Immunotherapy Research Acceleration for Translation and Evaluation | A. Hay | C. Steidl, M. Marra | $5,187,685 |
| Christian Steidl | Equipment Grant | 2021 | 2026 | Canadian Foundation for Innovation | Cancer single cell dynamics observatory | S. Aparicio | C. Steidl, A. Bouchard-Cote, K. Cheung, C. Eaves, D. Huntsman, P. Lansdorp, M. Levings, M. Marra, J. Penninger, | $5,992,026 |
| Christian Steidl | Operating Grant | 2021 | 2026 | Canadian Institute of Health Research (CIHR) | Somatic mutations in the JAK-STAT and IRF signaling pathways in Non-Hodgkin lymphoma | C. Steidl | S. Healy | $1,120,725 |
| Christine Lee | Operating Grant | 2018 | 2021 | Crohn’s & Colitis Foundation of Canada. Grants in Aid of Research | A randomized double-blind, placebo-controlled trial of fecal microbiota transplantation for the induction of remission in adults with active ulcerative colitis. | Lee CH, P Bercik, B Bressler, P Kim, D Loomes, P Moayyedi, D Petrunia, T Steiner, I Tai, W Zhang. | $375,000 | |
| Chun Seow | Operating Grant | 2017 | 2022 | CIHR | Mechanisms underlying the bronchodilatory effect of deep inspiration in health and asthma: from airway smooth muscle to the whole lung | Chun Seow | Peter Pare, Lu Wang | 132,345 |
| Chun Seow | Operating Grant | 2017 | 2023 | NSERC | Molecular mechanisms for length adaptation in smooth muscle cells | Chun Seow | 48,000 | |
| Cornelia Laule | Operating Grant | 2018 | 2021 | Multiple Sclerosis Society of Canada | The Pathological Basis of Magnetic Resonance Imaging in MS | Wayne Moore | Cornelia Laule | $350,363 |
| Cornelia Laule | Operating Grant | 2019 | 2022 | Department of Defense | Pathology and Pathogenesis of Clinical Progression in Multiple Sclerosis | Wayne Moore | Cornelia Laule | $370,000 |
| Cornelia Laule | Operating Grant | 2019 | 2024 | US National MS Society | Imaging markers for tissue damage and disease progression in MS | Alex Rauscher | Cornelia Laule | $980,000 |
| Cyril Blake Gilks | Operating Grant | 2019 | 2022 | Canadian Institute for Health Research (CIHR) | Omics, histopathology and AI: an integrative approach for biomarker discovery in ovarian cancer | Blake Gilks, Tim Salcudean, Ali Bashashati | $822,376 | |
| Dana Devine | Operating Grant | 2013 | 2022 | Burroughs Wellcome Fund | Refreshing the regulatory approach to ensuring the safety and efficacy of blood transfusion products | D. Devine | J. Zimring (Seattle) | US $500,000 |
| Dana Devine | Operating Grant | 2018 | 2022 | Canadian Blood Services | Optimizing rejuvenation to improve the product quality of pathogen-inactivated and g-irradiated red cell concentrates | W. Sheffield | D. Devine | $30,000 |
| Dana Devine | Operating Grant | 2012 | 2023 | Canadian Blood Services | Improvement of Blood Product Quality ($562,000 for 2019/20) | D. Devine | $570,000 | |
| David Goldfarb | Operating Grant | 2007 | 2021 | Canadian Immunization Research Network – Open operating grant | Burden Ethnographic Modeling Evaluation Qaujilisaaqtuq (BEMEQ) RSV. | Langley J (PI) | Goldfarb DM (co-PI) | $300,481.00 CDN |
| David Goldfarb | Operating Grant | 2021 | 2021 | Canadian Immunity Taskforce Occupational Hotspots Grant – Open operating grant, | Tracking COVID-19 for Safer Schools. | Lavoie P (PI), | Goldfarb DM (co-I) | $1,019,533.00 CDN |
| David Goldfarb | Operating Grant | 2019 | 2022 | Canadian Institutes of Health Research – Conditionally approved operating grant | Validation and Field Deployment of a Rapid Diagnostic Test for Syphilis in Arctic Communities | Yansouni C (PI) | Goldfarb DM (co-I) | $531,674.00 CDN |
| David Goldfarb | Operating Grant | 2020 | 2022 | Biomerieux Investigator Initiated Grant | Evaluation of Automated Blood culture System at Princess Marina Hospital, Botswana. | Goldfarb DM (PI) | $16, 000.00 US | |
| David Goldfarb | Operating Grant | 2021 | 2022 | Seroprevalence and Immunity among Paramedics (CORSIP) – Open operating grant | The COVID-19 Occupational Risks | Grunau B (PI) | Goldfarb DM (co-PI) | $2,138,931.47 CDN |
| David Goldfarb | Operating Grant | 2021 | 2023 | Centre for International Child Health Seed grant | Implementation of Saline Gargle Sample Collection for COVID-19 Diagnosis in Botswana | Goldfarb DM (PI) | $50, 000 CDN | |
| David Granville | Operating Grant | 2015 | 2022 | CIHR Foundation Grant | Granzymes in Injury, Inflammation and Repair | David Granville | $1,805,469 (Total) | |
| David Granville | Operating Grant | 2020 | 2022 | Muscular Dystrophy Canada | Profiling granzymes in inflammatory neuromuscular diseases | D.Granville | M. Berger | $100,000 |
| David Granville | Operating Grant | 2020 | 2022 | Michael Smith Foundation for Health Research I2C Grant (Phase II) | A Novel Therapeutic for Inflammatory Skin Diseases | D. Granville | viDA Therapeutics | $300,000 |
| David Granville | Operating Grant | 2020 | 2022 | Cancer Research Society | Granzyme B: A Novel Target for the Treatment of Radiodermatitis | D. Granville | K. Bennewith | $120,000 |
| David Granville | Operating Grant | 2020 | 2024 | Leo Foundation | Granzyme B: A Novel Therapeutic Target in Cutaneous Leishmaniasis | D. Granville | 2,023,506 (DKK) | |
| David Granville | Operating Grant | 2020 | Present | Wings for Life | An unbiased bioinformatic approach identifies sulfaphenazole as a promising neuroprotective therapy to improve motor and autonomic systems after spinal cord injury | Chris West and David Granville | 200,000 Euros | |
| David Huntsman | Team Grant | 2020 | 2021 | 2020 Cascadia Data Alliance Award Cascadia Funding Opportunity for Regional Collaboration in Data-Intensive | Pathology AI for a Federated Quality Assurance Program: Ovarian Cancer Pilot | D. Huntsman | A. Bashashati, I. Beshcastnikh, B. Gilks, H. Harris, S. Jones, T. Morgan, A. Talhouk | $125,000 (USD) |
| David Huntsman | Team Grant | 2019 | 2021 | University of British Columbia Grant for Catalyzing Research Clusters | Catalyzing Research Clusters: Gynecologic Cancer Initiative renewal + trainee stipend in digital health | G. Stuart | J. Mcalpine C. Gilks G. Hanley D. Huntsman | $230,000 |
| David Huntsman | Team Grant | 2020 | 2021 | Canadian Cancer Society Uterine Carcinosarcomas and other Aggressive Uterine Cancer Research Grant-2020 | p53 abnormal endometrial carcinomas: the most lethal and aggressive uterine cancer | J. McAlpine | A. Bashashati C. Gilks L. Hoang D. Huntsman A. Talhouk | $180,000 |
| David Huntsman | Team Grant | 2020 | 2021 | OvCAN1 | Passaging and molecular characterization of established non-serous human ovarian cancer cell lines | D. Huntsman | $82,461 | |
| David Huntsman | Team Grant | 2020 | 2021 | OvCAN1 | Protocol and organoid-derived xenograft of isogenic model of ARID1A/PIK3CA infected human endometrial cell | D. Huntsman | $69,249 | |
| David Huntsman | Team Grant | 2020 | 2021 | OvCAN1 | Development and molecular characterization of patient derived xenograft model | D. Huntsman | $42,203 | |
| David Huntsman | Operating Grant | 2015 | 2022 | CIHR | Canada Research Chair in Molecular and Genomic Pathology | D. Huntsman | 1,400,000 | |
| David Huntsman | Infrastructure Grant | 2019 | 2022 | Canada Foundation for Innovation | The Molecular Path: Connecting Biologic Insights to Improve Cancer Outcomes | Neilsen T | D. Huntsman, D. Schaeffer | $800,000 CDN |
| David Huntsman | Team Grant | 2021 | 2022 | Department of Defense | The STING paradox in serous ovarian cancers | D.Huntsman | D. Cochrane J. Bell | $275,000 (USD |
| David Huntsman | Team Grant | 2021 | 2022 | OvCAN1 | Development and Distribution of Clear Cell (CCOC) and Endometroid Ovarian Carcinoma (ENOC) Metastasis Model | D. Huntsman | $117,231 | |
| David Huntsman | Team Grant | 2021 | 2022 | University of British Columbia Grant for Catalyzing Research Clusters | Gynecologic Cancer Initiative | G. Stuart | J. Mcalpine C. Gilks G. Hanley D. Huntsman | $200,000 |
| David Huntsman | Team Grant | 2021 | 2022 | UBC Strategic Investment Fund (SIF) | Molecular and Advanced Pathology Core (MAPcore): a Translational Research Core Platform for UBC | D. Huntsman | D. Schaeffer T. Nielsen C. Gilks L. Hoang A. Bashashati M. Anglesio A Talhouk T. Ng S. Yip P. Sorensen S. Aparicio A. El Naggar E. Thompson | $160,000 |
| David Huntsman | Team Grant | 2018 | 2023 | Terry Fox Research Institute Program Grant | New Vistas on Cancer Biology and Treatment: Conceptual Advancements from the Forme Fruste Project | Huntsman D | Aparicio S, Shah S, Hirst M, Nielsen T, Morin, Sorensen P | $6,012,984 |
| David Huntsman | Team Grant | 2018 | 2023 | Canadian Cancer Society | Molecular pathogenesis of clear cell carcinoma of the ovary: towards better prevention and management strategies | Huntsman D | Morin G, Shah S, Gilks B, Underhill M | $1,249,013 |
| David Huntsman | Team Grant | 2021 | 2023 | OvCAN2/ Cancer Research Society | Developing optimal treatment combinations for small cell carcinoma of the ovary | Huang S. Wang Y. | Huntsman D. Foulkes W. | $225,000 |
| David Huntsman | Team Grant | 2021 | 2023 | OvCAN2/ Cancer Research Society | CTH in clear cell ovarian cancer: a targetable legacy of endometriotic origins | D. Huntsman | P. Sorensen | $225,000 |
| David Huntsman | Team Grant | 2021 | 2023 | OvCAN2/ Cancer Research Society | Next generation DNA repair inhibitors for ovarian cancer treatment | P. Stirling | P. Hieter JY. Masson D. Huntsman | $225,000 |
| David Huntsman | Team Grant | 2021 | 2023 | Rivkin Centre | Combining MEK inhibition with oncolytic viral therapy as a novel treatment for low grade serous ovarian carcinoma | D. Huntsman | D. Cochrane M. Carey J. Bell R. Singaravelu | $75,000 USD |
| David Huntsman | Operating Grant | 2017 | 2024 | CIHR Foundations Grant 2016-2017 | Mutation, cell context, and the pathogenesis of ovarian cancer | D. Huntsman | S. Aparicio B. Gilks M. Hirst G. Morin T. Nielsen M. Underhill P. Yong | $2,660,195 |
| David Huntsman | Team Grant | 2019 | 2024 | CIHR Project Grant: Spring 2019 | Omics, Histopathology and AI: An Integrative Approach for Biomarker Discovery in Ovarian Cancer | Gilks CB (PI) | D. Huntsman, A. Bashashati, S.E. Salcudean, P. Abolmaesumi, M. Anglesio, A. Talhouk, M. Carey, A. Karnezis | $822,376 CDN |
| David Huntsman | Team Grant | 2021 | 2025 | Canadian Institutes of Health Research | Exploit the metabolic vulnerabilities in SWI/SNF-deficient cancer | Y. Wang | D. Huntsman R. Geltink G. Morin | $688,501 |
| David Huntsman | Team Grant | 2021 | 2026 | Canada Foundation for Innovation | Cancer Single Cell Dynamics Observatory | S. Aparicio | D. Huntsman | $5,992,026 |
| David Huntsman | Team Grant | 2021 | 2027 | Canadian Institutes of Health Research | Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER) | J.N. McAlpine/ K. Han | S. Ferguson A. Fyles C. Gilks D. Huntsman S. Lheureux Z. Liu H. Mackay A. Oza T. Stockley A. Talhouk S. Welch | $1,082,474 |
| David Schaeffer | Operating Grant | 2019 | 2021 | Canadian Cancer Society (CCS) - Innovation grant | Targeting metabolic plasticity in pancreatic cancer | DF. Schaeffer | D. Renouf J. Karasinska (Co-Applicant) | $199,126 |
| David Schaeffer | Infrastructure Grant | 2019 | 2021 | John R. Evans Leaders Fund – Funding for research infrastructure | The Molecular Path: Connecting Biologic Insights To Improve Cancer Outcomes | T. Nielsen | DF. Schaeffer, DG. Huntsman | $800,000 |
| David Schaeffer | Operating Grant | 2018 | 2022 | Terry Fox Research Institute (TFRI) | Enhanced Pancreatic Cancer Profiling for Individualized Care (EPPIC) | DF. Schaeffer DJ. Renouf | S. Gallinger O. Bathe G. Zogopoulos | $4,984,557 (my portion is 40% over 5 years) |
| David Schaeffer | Operating Grant | 2021 | 2022 | Canadian Cancer Society (CCS)/ Canadian Institutes of Health Research (CIHR) Spark Grant: Novel Technology Applications in Cancer Prevention and Early Detection (SPARK-21) | Long read DNA methylation sequencing for early detection of pancreatic Adenocarcinoma | M. Marra | DF Schaeffer; S Jones; P. Bhatti, D. Renouf; J. Nelson; K. O'Neill; L. Williamson | $150,000 |
| David Schaeffer | Infrastructure Grant | 2021 | 2023 | Strategic Innovation Fund (SIF), UBC | Molecular and Advanced Pathology Core: A Translational Research Core Platform | DG. Huntsman, T. Nielsen, DF. Schaeffer | $160,000 | |
| David Schaeffer | Operating Grant | 2021 | 2023 | Lustgarten Foundation - Therapeutics Focused Research Program | Local and systemic metabolic dysfunction in pancreatic cancer – Bench to bedside | J. Johnson | DF. Schaeffer; DJ Renouf; T Elliott; J Kopp | $1,199,715 (USD) |
| David Schaeffer | Operating Grant | 2020 | 2024 | Canadian Institute of Health Research (CIHR) | Mechanisms by which hyperinsulinemia promotes pancreatic cancer | J. Johnson | DF. Schaeffer, DJ. Renouf, J. Kopp | $1,090,125 |
| David Schaeffer | Operating Grant | 2021 | 2027 | Canadian Institutes of Health Research (CIHR) | Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colorectal Cancer: A Multicentre Phase II/III Randomised Controlled Trial (DYNAMIC-III) | John Loree | DF Schaeffer | $1,426,724 |
| Decheng Yang | Operating Grant | 2017 | 2023 | NSERC | Mechanisms of selective host gene translation regulation in picornavirus infection | Decheng Yang | $210,000 | |
| Decheng Yang | Operating Grant | 2020 | 2025 | CIHR | Role of transcription factor NFAT5 in viral myocarditis: a novel strategy for therapy | Decheng Yang | Bruce McManus | 604,350 |
| Dirk Van Niekerk | Team Grant | 2015 | 2022 | CIHR | Optimizing the detection and management of cervical cancer in the evolving era of molecular based cervical cancer screening | Dr. Gina Ogilvie | Dr. Dirk van Niekerk | C$2,714,493 |
| Dirk Van Niekerk | Team Grant | 2017 | 2022 | BC Cancer Foundation | Using an Online intervention for self-collection based HPV testing to improve cervical cancer screening rates in the Fraser Region of BC | Dr. Dirk van Niekerk | $151,625 | |
| Dirk Van Niekerk | Team Grant | 2018 | 2023 | NIH | Addressing emerging health system priorities in cervical cancer prevention: determining optimal strategies for HPV based screening and triage. | Dr. Gina Ogilvie | Dr. Dirk van Niekerk | US$ 1,749,770 |
| Ed Pryzdial | Operating Grant | 2019 | 2022 | Heart and Stroke Foundation | Hemostasis Modulated by Enveloped Viruses | Ed Pryzdial | $100,000 | |
| Emma Strong | Other (education innovation) Grant | 2021 | 2024 | Dr. Donald B. Rix Pathology & Laboratory Medicine Research Grant, BCCWH. | Assessing the feasibility of implementing non-invasive genetic diagnosis (NIPD) in the Division of Genome Diagnostics | Dr. Lindsay Brown, PhD FCCMG | Dr. Emma Strong, PhD FCCMG; Dr. Tanya Nelson, PhD FCCMG; Dr. Christine Tyson, PhD, FCCMG; Dr. Karla Bretherick PhD FCCMG; Dr. Sylvie Langlois MD FRCPC FCCMG; Dr. Hillary Vallance MD FRCPC FCCMG; Kim Seath CGC. | $50,000 |
| Eric Belanger | Operating Grant | 2015 | 2021 | Prostate Cancer Canada | Movember Team Grant - Development of a targeted oncolytic virus vaccine for the treatment of metastatic prostate cancer | Dr. John Bell | Jean-Simon Diallo, Sébastien Hotte, Brian Lichty, Fred Saad, Eric Belanger, Jonathan Bramson, Rodney Breau, Dean Fergusson, Derek Jonker, Andrea McCart, David Stojdl, Yonghong Wan | $4,990,498 |
| Eric McGinnis | Operating Grant | 2020 | 2022 | Blood Efficiency Accelerator Program Award 2020-2022 Agency: Canadian Blood Services | Demonstration of genetic blood group transition in patients undergoing ABO-mismatched hematopoietic stem cell transplantation by peripheral blood quantitative polymerase chain reaction targeting the ABO locus | Andrew Shih | Eric McGinnis | 15,990 |
| Fumio Takei | Operating Grant | 2017 | 2022 | CIHR | Immunological memory of innate lymphoid cells and allergic lung inflammation | F. Takei | 164,475 | |
| Fumio Takei | Operating Grant | 2018 | 2023 | CIHR | CD127 in the development and function of Type 2 innate lymphoid cells (ILC2s) | N. Abraham | F. Takei | 1,036,575 |
| Fumio Takei | Operating Grant | 2020 | 2025 | CIHR | Tissue resident and migratory group 2 innate lymphoid cells in health and disease | F. Takei | 156,825 | |
| G R Wayne Moore | Operating Grant | 2018 | 2022 | Multiple Sclerosis Society of Canada | Characterizing the neuroprotective roles of bHLH proteins Npas4 and ARNT2 in inflammatory neurodegeneration related to multiple sclerosis | J Quandt | GRW Moore, S Bamji | $346,400 |
| G R Wayne Moore | Operating Grant | 2018 | 2023 | Multiple Sclerosis Society of Canada | The Pathologic Basis of Magnetic Resonance Scanning in Multiple Sclerosis | GRW Moore | A.L Traboulsee, R.L.Carruthers, D.K.B. Li, T. Vertinsky, A.L. MacKay, J Quandt, C. Laule | $350,212.42 |
| G R Wayne Moore | Operating Grant | 2021 | 2023 | Alzheimer’s Association | Progranulin’s Effects on Lysosomal Dysfunction, White Matter Pathology, and Degeneration | Petrucelli | IRA Mackenzie, GRW Moore | $100,000 |
| Gang Wang | Operating Grant | 2019 | 2022 | AP residency program | Molecular Biomarkers of Triple Negative Breast Cancer | Dr. T. Salisbury (resident) Dr. G. Wang (supervisor) | 3000 | |
| Gang Wang | Operating Grant | 2020 | Present | AP residency program | Genotyping “Unclassified” Renal Cell Carcinoma | Dr. C. Pryma (resident) Dr. G. Wang (supervisor) | 3000 | |
| Gerald Krystal | Operating Grant | 2017 | 2021 | Lotte & John Hecht Memorial Foundation | Ketogenic diet and chemotherapy to affect response to breast cancer treatment (The KETO-CARE Study) G. Krystal - Collaborator - Amount total to GK $439,190 | J.S. Volek | M. Lustberg M. Knopp | 439,190 |
| Gerald Krystal | Operating Grant | 2019 | 2021 | Lotte & John Hecht Memorial Foundation | A phase II randomized cross-over study of the efficacy and safety of omega 3 fatty acid supplements on lung cancer-promoting inflammatory markers in heavy smokers. | G. Krystal | S. Lam | 282,845 |
| Gerald Krystal | Operating Grant | 2018 | 2022 | Lotte & John Hecht Memorial Foundation | Continuing studies into the role that diet plays in preventing cancer. | G. Krystal | 825,000 | |
| Gerald Krystal | Operating Grant | 2021 | 2024 | Lotte & John Hecht Memorial Foundation | Optimizing Diets During Cancer Treatment | G. Krystal | 961,130 | |
| Glen Tibbits | Operating Grant | 2016 | 2021 | Canadian Institutes of Health Research (CIHR) | Hypertrophic cardiomyopathy: etiology involving troponin mutations | Glen Tibbits | 960,000 | |
| Glen Tibbits | Operating Grant | 2017 | 2022 | Canadian Institutes of Health Research (CIHR) 2017/5 - 2022/4 | Investigating Pharmacogenetic Mechanisms of Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell-Derived Cardiomyocytes | Liam Brunham | Glen Tibbits | 675,000 |
| Glen Tibbits | Operating Grant | 2018 | 2023 | Canadian Institutes of Health Research (CIHR) | Using translational models to find drug therapies for long QT syndrome | Thomas Claydon | Glen Tibbits; | 675,000 |
| Glen Tibbits | Operating Grant | 2018 | 2023 | Canadian Institutes of Health Research (CIHR) | Arrhythmogenic mutations in the neonate cardiac contractile element | Glen Tibbits | 790,000 | |
| Glen Tibbits | Operating Grant | 2020 | 2023 | BC Children's Hospital Mining for Miracles | Infrastructural support for the establishment of the Cellular and Regenerative Medicine Centre (CRMC) at BC Children's Hospital Research Institute | Francis Lynn; Glen Tibbits; Shubhayan Sanatani | 3,385,000 | |
| Glen Tibbits | Operating Grant | 2020 | 2023 | Stem Cell Network Accelerating Clinical Translation | Pipeline towards stem cell-driven personalized medicine for atrial fibrillation | Zachary Laksman | Glen Tibbits; Gordon Keller | 600,000 |
| Glen Tibbits | Operating Grant | 2020 | 2025 | Canadian Institutes of Health Research (CIHR) | Quality control and pharmacological rescue of heteromeric long QT mutants | Alvin Shrier | Glen Tibbits | 768,825 |
| Glen Tibbits | Operating Grant | 2020 | 2025 | Canada Foundation for Innovation (CFI) | High throughput high content electrophysiologic imaging of human-induced pluripotent stem cell-derived cardiomyocytes | Zachary Laksman | David Vocadlo; Glen Tibbits | 834,891 |
| Gordon Ritchie | Operating Grant | 2020 | 2021 | Genome BC | Development of Sensitive and Quantitative Molecular Technologies for SARS-CoV-2 Detection | Christopher Lowe, Zabrina Brumme | Co-Investigators: Dr. Gordon Ritchie, Dr. Julio Montaner, Dr. Marc Romney, Dr. Chanson Brumme, Dr. Victor Leung, Dr. Aleksandra Stefanovic, Dr. Nancy Matic | 101,000 |
| Gordon Ritchie | Operating Grant | 2020 | Present | CFI Exceptional Opportunities Fund-COVID19 | In submission | |||
| Gordon Ritchie | Operating Grant | 2020 | Present | COVID-19 Immunology Task Force | Integrating longitudinal epidemiologic, virologic and immunologic analyses to understand COVID-19 immunity and infection outcomes in long term care | Dr. Marc Romney | Dr. Gordon Ritchie, Dr. Brumme, Dr. John Harding, Dr. Chanson Brumme, Dr. Jonathan Choy, Dr. Mari DeMarco, Dr. Jeffrey Joy, Dr. Christopher Lowe, Dr. Victor Leung, Dr. Nancy Matic, Dr. Julio Montaner, Dr. Masahiro Niikura | $1,200,000 |
| Gordon Ritchie | Operating Grant | 2021 | Present | BC Ministry of Health COVID-19 Research Priorities | Advancing real-time SARS-CoV-2 genomic analyses to enable rapid action in healthcare-related SARS-CoV-2 outbreaks | Dr. Chanson Brumme, Dr. Christopher Lowe | Dr. Zabrina Brumme, Dr. Jeffrey Joy, Dr. Victor Leung, Dr. Nancy Matic, Dr. Gordon Ritchie, Dr. Marc Romney | $7,000 |
| Graham Sinclair | Operating Grant | 2019 | 2021 | Canadian Donation and Transplantation Research Program Research Innovation Grant | Investigating serum immunometabolomic profiles associated with pediatric kidney and heart transplant alloimmune outomes | Tom Blydt-Hansen | Or Golan, Katey Armstrong, David Wishart, Simou Ursche, Graham Sinclair, Atul Sharma | $30,000 |
| Graham Sinclair | Equipment Grant | 2020 | 2021 | BC Children's Hospital Foundation Crystal Ball Gala | Next-Generation Technologies for BC's Next Generation | Graham Sinclair, Tanya Nelson, Suzanne Vercauteren | $5 million | |
| Helene Cote | Operating Grant | 2020 | 2021 | CIHR Bridge Grant | The Positively Dance Pilot Program: Examining the Feasibility of a Peer Research Associate-Led Dance Program for Women Living With HIV | Eli Puterman | Helene Cote Mark Beauchamp Angela Kaida Erica Bennett Melanie Murray | 100000 |
| Helene Cote | Operating Grant | 2017 | 2022 | NIH- R01 | Personality and Health: A Longitudinal Study Expanded Specific Aims | Grant Edmonds | Sarah Hampson, Helene Cote, L. Goldberg, P Hill, + Drs. Oshiro, Wilson, & Terraciano, | USD $1,151,000 (approximately $225,000 to me) |
| Helene Cote | Operating Grant | 2019 | 2022 | CIHR | The impact of chronic/latent viral infections on aging | Helene Cote | $450,000 | |
| Helene Cote | Operating Grant | 2021 | 2022 | CIHR HIV Clinical Trial Network | Assessing Fertility in Youth Living with HIV Since Childhood | Melanie Murray | $50,000 | |
| Helene Cote | Operating Grant | 2018 | 2023 | CIHR -Project Grant -Fall 2017 competition | Placenta mitochondrial dysfunction and preterm birth | Helene Cote | $1,239,300 | |
| Helene Cote | Operating Grant | 2018 | 2023 | CIHR HIV Clinical Trial Network | Preterm Birth in HIV - Positive Pregnancies | Isabelle Boucoiran | Helene Cote Deborah Money | $55,800 |
| Helene Cote | Operating Grant | 2020 | 2023 | CIHR | Hormones and healthy aging in women living with HIV: A study for, with and by community | Melanie Murray | Helene Cote, Angela Kaida, Valerie Nicholson | 450000 |
| Helene Cote | Operating Grant | 2021 | 2023 | NIH | CMV Dynamics and Transmission Among Pregnant Women Living with HIV | Isabelle Boucoiran | $163,091 USD | |
| Helene Cote | Operating Grant | 2019 | 2024 | CIHR | The BCC3 cohort: Cellular aging in women living with HIV | Helene Cote | $822,375 | |
| Helene Cote | Operating Grant | 2021 | 2025 | CIHR | Role of Female Sex Hormones on Aging in Women Living with HIV | Melanie Murray | Helene Cote, Angela Kaida, | 382,500 |
| Helene Cote | Operating Grant | 2021 | 2025 | CIHR | CMV Dynamics and Transmission in Pregnancy: Comparison Between Women Living with and without HIV | Isabelle Boucoiran Soren Gantt | $884,530 | |
| Helene Cote | Operating Grant | 2021 | 2026 | CIHR HIV Clinical Trial Network | CTN 355 The British Columbia CARMA-CHIWOS Collaboration (BCC3): the role female sex hormones and chronic/latent co-infections and on cellular aging and comorbidities in women living with HIV. | Melanie Murray | Helene Cote Angela Kaida | $61,083 |
| Hilary Vallance | Operating Grant | 2019 | 2021 | BC Children's Hospital Research Institute | Assessment of parental psychosocial stress related to newborn screening for Cystic Fibrosis | Hilary Vallance | Mark Chilvers Robin Hayeems | 19,320 |
| Honglin Luo | Operating Grant | 2018 | 2021 | Heart & Stroke Foundation of Canada (Grant-in-aid) | Enteroviral control of autophagy: Relevance to heart failure | Honglin Luo | Bruce McManus | $227,250 |
| Honglin Luo | Operating Grant | 2018 | 2021 | PHCRI and VCHRI Innovation and Translational Research Award | Engineering coxsackievirus for the treatment of KRAS-mutant lung adenocarcinoma | Honglin Luo | William Jia, William Lockwood | $75,000 |
| Honglin Luo | Other (development grants) Grant | 2020 | 2021 | UBC VP Research & Innovation (Research Facility Support grant) | Core service facilities at the James Hogg Research Centre | Honglin Luo | Scott Tebbutt | $75,000 |
| Honglin Luo | Operating Grant | 2016 | 2022 | NSERC (Discovery grant) | Understanding the interplay between coxsackievirus and the host ubiquitin-proteasome system | Honglin Luo | N/A | $264,000 |
| Honglin Luo | Operating Grant | 2020 | 2022 | Cancer Research Society (Discovery grant) | Novel oncolytic virus for lung cancer treatment | Honglin Luo | William Lockwood | $120,000 |
| Honglin Luo | Operating Grant | 2020 | 2022 | Canadian Lung Association (Grant-in-aid) | Novel oncolytic virus for lung cancer treatment (Declined) | Honglin Luo | William Lockwood | $50,000 |
| Honglin Luo | Under Review | 2021 | 2022 | UBC VP Research & Innovation (Research Facility Support grant) | Genetically Engineered Models (GEM) facility - James Hogg Research Centre | Pascal Bernatchez | Honglin Luo | $49,967 |
| Honglin Luo | Operating Grant | 2018 | 2023 | CIHR (Project grant) | Host cell protein substrates of enterovirus proteases | Eric Jan | Honglin Luo, Christopher Overall | $726,750 |
| Honglin Luo | Operating Grant | 2018 | 2023 | CIHR (Project grant) | Role of enterovirus infection in amyotrophic lateral sclerosis (Ranked #4/72 in NSA Panel) | Honglin Luo | Neil Cashman | $1,002,150 |
| Honglin Luo | Operating Grant | 2019 | 2023 | MITACS (Accelerate grant) | Development of coxsackievirus B3 as an oncolytic virus for KRAS-mutant lung cancer treatment | Honglin Luo | N/A | $180,000 |
| Honglin Luo | Operating Grant | 2021 | 2023 | ALS Canada-Brian Canada (Discovery grant) | Cytosolic DNA sensing in ALS-related neuroinflammation | Honglin Luo | Neil Cashman | $125,000 |
| Honglin Luo | Operating Grant | 2021 | 2024 | CIHR (COVID-19 Research Gaps and Priorities) | Repurposing an FDA-approved anti-gout drug for the treatment of COVID-19 | Honglin Luo | Matthew Miller | $562,275 |
| Honglin Luo | Operating Grant | 2020 | 2025 | CIHR (Project grant) | Enterovirus subversion of the autophagy pathway (ranked #3/38 in VVP panel) | Honglin Luo | Yasir Mohamud | $734,400 |
| Honglin Luo | Operating Grant | 2022 | 2027 | NSERC (Discovery grant) | Autophagy mechanism of coronaviral infection: Lessons from enteroviruses | Honglin Luo | $200,000 | |
| Honglin Luo | Under Review | 2021 | Present | Heart & Stroke Foundation of Canada (Grant-in-aid) | Innate mechanisms of viral myocarditis: Role of the cytosolic DNA-sensing pathway | Honglin Luo | Yasir Mohamud | $293,500 |
| Hui-Min Yang | Other (development grants) Grant | 2015 | Present | Columbia University Medical Center, Department of Pathology and Cell Biology Intradepartmental Research Grant | GATA3 Immunohistochemistry in Adenocarcinoma of the Ampullary Region | Hui-Min Yang | Sonya Purushothaman, Helen E Remotti, Stephen M. Lagana MD, and Susan J Hsiao. | 6500 |
| Hui-Min Yang | Other (development grants) Grant | 2017 | Present | Columbia University Medical Center, Department of Pathology and Cell Biology Intradepartmental Research Grant | Immunohistochemistry of Benign Versus Malignant Biliary Tract Brushing Specimens. | Hui-Min Yang | Anjali Saqi, Anna Lee, Helen Remotti. | 6500 |
| Hui-Min Yang | Other (development grants) Grant | 2017 | Present | Vancouver General Hospital, Department of Pathology and Laboratory Medicine, Intradepartmental Research Fund | Title: Topography, Morphology and Etiology of Lymphocytic Gastritis, A Single Institution Experience | Hui-Min Yang | Raymond Yip, Lawrence Lee, Lik Hang Lee, David Schaeffer, | 3000 |
| Ian Mackenzie | Operating Grant | 2016 | 2021 | ALS Canada & Brain Canada Hudson Translational Team Grant | Pathogenic mechanism of C9orf72 haploinsufficiency in ALS/FTD: a road to therapeutic discovery | J. Robertson | 1,600,000 | |
| Ian Mackenzie | Operating Grant | 2017 | 2021 | NIH (US) | PREDICT-ADFTD: Multimodal Imaging Prediction of AD/FTD and Differential Diagnosis | L. Wang | H. Rosen | 2,630,086 USD |
| Ian Mackenzie | Operating Grant | 2017 | 2022 | CIHR | The Canadian ADNI Brain Donation and Neuropathology Network (CABIN) –Optimizing Canadian Participation in the Neuropathology Program of ADNI | I. Mackenzie | H. Chertkow, R. Hsiung | 1,065,000 |
| Ian Mackenzie | Operating Grant | 2020 | 2022 | CIHR | Diagnostic and predictive biomarkers for frontotemporal dementia with TDP-43 pathology | R Hsiung | I Mackenzie | 100,000 |
| Ian Mackenzie | Operating Grant | 2020 | 2022 | Alzheimer's Association (US) | Progranulin’s Effects on Lysosomal Dysfunction, White Matter Pathology, and Degeneration | I Mackenzie | L Petrucelli | 100,000 USD |
| Ian Mackenzie | Operating Grant | 2019 | 2024 | NIH (US) | ALLFTD – ARTFL LEFFTDS Longitudinal Frontemporal Lobar Degeneration (1U19AG063911-01) | B Boeve (Mayo Clinic) | H Rosen (UCSF), A Boxer (UCSF) | 63,809,894 USD |
| Inna Sekirov | Other (development grants) Grant | 2020 | 2021 | Michael Smith Foundation for Health Research | Accelerating SARS-CoV-2 SEroprevalence SurveyS through Dried Blood Spots (ASSESS-DBS) | Muhammad Morshed | Inna Sekirov | 150,000 |
| Inna Sekirov | Other (development grants) Grant | 2021 | 2021 | Genome BC | One Health Genomics: COVID-19 Adaptation investigation in mink (and spillover to other animals) COVID-19 AIM project | Natalie Prystajecky | Chelsea Himsworth - Co-PI Inna Sekirov, Erin Fraser, Mel Krajden, Michelle Coombe, Veronic Clair - Co-Applicants | 250,000 |
| Inna Sekirov | Operating Grant | 2020 | 2021 | Canadian Institutes of Health Research | COVID-19 household study to assess secondary attack rates and the proportion asymptomatic, including children | Cecil Tremblay | Inna Sekirov - Co-Applicant | 1,017,142 |
| Inna Sekirov | Other (development grants) Grant | 2020 | 2021 | Michael Smith Foundation for Health Research | Population-based study of coronavirus antibody cross-reactivity to inform SARS-CoV-2 seroprevalence surveys, severity profiles, and vaccine strategies | Agatha Jassem | Inna Sekirov - Co-Applicant | 150,000 |
| Inna Sekirov | Other (development grants) Grant | 2021 | 2030 | U.S. Department of Health and Human Services Tuberculosis Consortium Trials Services | Centers for Disease Control Tuberculosis Treatment Consortium | Dick Menzies | Inna Sekirov - Co-Applicant | 13,589,077 USD |
| Jacqueline Quandt | Operating Grant | 2018 | 2021 | Multiple Sclerosis Society of Canada | The Pathologic Basis of Magnetic Resonance Imaging in Multiple Sclerosis | Wayne Moore | Quandt Jacqueline, Carruthers, Robert; Laule, Cornelia; Li, David; MacKay, Alexander; Traboulsee, Anthony; Vertinsky, Alexandra; | 350,363 |
| Jacqueline Quandt | Operating Grant | 2018 | 2021 | UBC/Vancouver General Hospital Foundation | Characterizing novel pathways to drive neuroprotection and repair in MS | Jacqueline Quandt | 647,800 | |
| Jacqueline Quandt | Operating Grant | 2020 | 2021 | VGH and UBC Hospital Foundation | Characterizing novel pathways to drive neuroprotection and repair in MS III: Brain Campaign Initiative | Jacqueline Quandt | $68,392 | |
| Jacqueline Quandt | Operating Grant | 2018 | 2022 | Multiple Sclerosis Society of Canada | Characterizing the neuroprotective roles of bHLH proteins Npas4 and ARNT2 in inflammatory neurodegeneration related to multiple sclerosis | Jacqueline Quandt | Co-investigators: Wayne Moore, Shernaz Bamji | 346,400 |
| Jacqueline Quandt | Operating Grant | 2021 | 2022 | VGH & UBC Hospital Foundation | Characterizing novel pathways to drive neuroprotection and repair in MS IV: Brain Campaign Initiative | Jacqueline Quandt | 150,000 | |
| Jacqueline Quandt | Team Grant | 2018 | 2023 | Brain Canada, MS Society of Canada, Biogen | Progressive MS Canadian Cohort | Jiwon Oh | Immunology Pillar: J. Quandt, C. Moore, S. Dunn, F. Guiliani, M. Rangachari, N.Arbour, A. Prat | 6,590,000 |
| Jacqueline Quandt | Operating Grant | 2020 | 2023 | Multiple Sclerosis Society of Canada | Characterizing inflammatory and neurodegenerative pathways driving clinical disease in the NR1H3 (LXRA) R415Q model of primary progressive multiple sclerosis | Jacqueline Quandt | C. Vilarino- Guell, W. Song, F. Rossi, W. Tetzlaff | 351,660 |
| Jacqueline Quandt | Under Review | 2021 | Present | CIHR | Targeting inflammatory and neurodegenerative pathways relevant to progression in the NR1H3 (LXRA) R415Q model of primary progressive multiple sclerosis | Jacqueline Quandt | C. Villarino-Guell, F. Rossi, W. Tetzlaff | $1,190,000 |
| James Lan | Operating Grant | 2020 | 2021 | Vancouver Coastal Health Institute | Comprehensive immune profiling of solid organ transplant recipients with Covid-19 | JH Lan | P Keown, M Sekhon, C Wellington, E Yoshida, M Morshed, et al. | $40,000 (CAD) |
| James Lan | Operating Grant | 2020 | 2021 | Vancouver Coastal Health Institute | Evaluation of patient perspectives on the utility and equity of a willing to cross kidney allocation strategy to improve transplant access | JH Lan | MC Fortin | $15,000 (CAD) |
| James Lan | Operating Grant | 2020 | 2022 | Kidney Foundation of Canada | Clinical significance of preformed HLA antibodies in kidney transplant recipients without sensitization: bening or pathologic? | JH Lan | H Gebel, F Claas, M Oellerich R Liwski et al. | $120,000 (CAD) |
| James Lan | Operating Grant | 2019 | 2022 | Barbara Opperman Kidney Health Research Grant | Implementation of a Canadian willing to cross program as a strategy to improve access for highly sensitized patients | JH Lan | A Jevnikar, R Liwski, S Heidt, F Claas, MC Fortin, et al. | $150,000 (CAD) |
| James Lan | Operating Grant | 2018 | 2024 | Genome Canada | Precision Medicine CanPREVENT AMR: Applying Precision Medicine Technologies in Canada to Prevent Antibody Mediated Rejection and Premature Kidney Transplant Loss | P Keown | R Sapir-Pichhadze, T Caulfield, S Bryan, JH Lan , (Pillar 3 lead), H Wong, et al. | $10,834,538 (CAD) |
| James Lan | Operating Grant | 2021 | 2026 | Michael Smith Foundation for Health Research Scholar | Implementation of a Canadian willingness to cross program: A strategy to increase access to kidney transplantation for highly sensitized patients | JH Lan | $450,000 (CAD) | |
| James Zlosnik | Group Grant | 2021 | 2021 | BC Children’s Hospital Research Institute, Healthy Starts Catalyst Grant | Molecular epidemiology and immune responses to Klebsiella infection in children to improve understanding of pathogenesis and inform development of a Klebsiella vaccine | Manish Sadarangani | Ashley Roberts, Peter Tilley, Kristopher Kang and James Zlosnik | |
| James Zlosnik | Group Grant | 2021 | 2021 | COVID-19 Immunology Task Force Grant | The PREVENT-COVID in Seniors Study: PRospEctiVe EvaluatioN of immuniTy after COVID-19 vaccines in Seniors | Agatha Jassem and Manish Sadarangani | Inna Sekirov, Muhammed Morshed, Mel Kradjen, Danuta Skowronski, James Zlosnik, Sofia Bartlett, Citali Marquez | |
| Jayachandran Kizhakkedathu | Team Grant | 2018 | 2021 | Canadian Institutes of Health Research (CIHR) & Natural Sciences and Engineering Research Council of Canada (NSERC) | Platform technology for blood diagnostics integrating microneedle blood sampling and quantum-dot based multiplexed assays | Kizhakkedathu, JN (PI); Algar, RW (PI); Conway, EM (PI); Stoeber, B ( Nominated PI) | 712050 | |
| Jayachandran Kizhakkedathu | Operating Grant | 2019 | 2021 | Thalassemia Foundation of Canada | Heart protection via targeted chelation therapy for transfusion dependent thalassemia | Kizhakkedathu, JN | 61,600 | |
| Jayachandran Kizhakkedathu | Operating Grant | 2020 | 2021 | Canadian Glycomics Network (Grant-in-aid) | Towards universal blood through enzymatic red blood cell modification | Stephen G. Withers | Jayachandran Kizhakkedathu | 110000 |
| Jayachandran Kizhakkedathu | Operating Grant | 2017 | 2022 | CIHR | Next Generation Antithrombotics: Safer Inhibitors for Thrombosis that Targets Procoagulant Polyanions | Kizhakkedathu, JN | Haynes, C; Conway EM. | 181, 500 |
| Jayachandran Kizhakkedathu | Infrastructure Grant | 2021 | 2022 | UBC VP Research | UBC Centre for Blood Research- General Infrastructure | Kizhakkedathu, J | 49331 | |
| Jayachandran Kizhakkedathu | Operating Grant | 2018 | 2023 | Natural Sciences and Engineering Research Council of Canada (NSERC) | Basic Studies on the Development of Functional Biodegradable Polymers and Surface Grafted Polymer Brushes | Kizhakkedathu, JN | 230000 | |
| Jayachandran Kizhakkedathu | Operating Grant | 2020 | 2023 | Canadian Institutes of Health Research (CIHR) | Novel hyperbranched polyglycerol-derived biliary excretable osmotic agents for peritoneal dialysis - preclinical evaluation | Caigan Du (NPI), Jayachandran Kizhakkedathu (PI) | 474299 | |
| Jayachandran Kizhakkedathu | Operating Grant | 2020 | 2023 | Canadian Institutes of Health Research (CIHR) Collaborative Health Research Projects | Next Generation Platelet Storage Devices for Safe and Efficient Transfusion | Jayachandran Kizhakkedathu (NPI), Dana Devine (PI) | Donald E. Brooks | 723702 |
| Jayachandran Kizhakkedathu | Operating Grant | 2020 | 2023 | Canadian Institutes of Health Research (CIHR) | Improved organ transplant across the ABO barrier through enzymatic removal of antigens | Marcelo Cypel (PI) and Stephen Withers (NPI) | Jayachandran Kizhakkedathu, Lorri West | 870000 |
| Jayachandran Kizhakkedathu | Operating Grant | 2021 | 2024 | Canadian Institutes of Health Research (CIHR) | Novel Infection Resistant Coating in an Era of Drug Resistant Bacteria for the Treatment and Prevention of Medical Device Infection | Kizhakkedathu, JN (NPI) | Chew, B, Lange (PI) | 173,400 |
| Jayachandran Kizhakkedathu | Operating Grant | 2020 | 2025 | Canadian Institutes of Health Research (CIHR) | Novel endothelial engineering and localized immunosuppression approaches for the protection of organ transplants | Jayachandran Kizhakkedathu (NPI) | Jonathan Choy, Caigan Du, Christopher Nguan | 917,500 |
| Jayachandran Kizhakkedathu | Operating Grant | 2021 | 2025 | US Department of Defense office | Toward Universal Whole Blood in the Battlefield | Stephen Withers (NPI) Kizhakkedathu, J (PI) | Peter Rahfeld Jason Rall | US$ 4026689 |
| Jayachandran Kizhakkedathu | Under Review | 2021 | 2029 | Canada Research Chair Program | Immunomodulation Materials and Immunotherapy | Kizhakkedathu, JN | 1400000 | |
| Jocelyn Srigley | Operating Grant | 2021 | Present | COVID-19 Immunity Task Force | COVID-19 Hot Spots | Brian Grunau | Richard Armour, Vilte Barakauskas, Sheldon Cheskes, James Christensen, Paul Demers, Ian Drennan, David Goldfarb, Jennie Helmer, Agatha Jassem, Sandra Jenneson, Tracy Kirkham, Jocelyn Srigley | $2,129,411 CAD |
| Jocelyn Srigley | Operating Grant | Present | BC Children's Hospital Research Institute | Evidence to Innovation Seed Grant | Jocelyn Srigley | Kim Corace, Leandre Fabrigar, Gary Garber, Tara Macdonald | $10,000 CAD | |
| Jocelyn Srigley | Operating Grant | Present | Hamilton Health Sciences | Quality and Patient Safety Grant | Jocelyn Srigley | Dominik Mertz | $10,000 CAD | |
| Jocelyn Srigley | Operating Grant | Present | Association of Medical Microbiology and Infectious Disease (AMMI) Canada | AMMI Canada/ Astellas Post Residency Fellowship | Jocelyn Srigley | Michael Gardam | $70,000 CAD | |
| Jonathan Bush | Operating Grant | 2021 | 2021 | Society for Pediatric Pathology Young Investigator Research Grant 03/13/2021 | High-resolution mass spectrometry proteomic analysis in osteosarcoma with a focus on activated beta-catenin | Jonathan Bush | $25,000 (USD) | |
| Jonathan Bush | Operating Grant | 2021 | 2021 | BC Children’s Hospital Research Institute 2021 Seed Grant. 02/26/2021. | Novel Mass Spectrometry Based Spaitial-Omics: Investigation into the Micro-Environment of Pediatric Wilms Tumor | Jonathan Bush | $30,000 | |
| Jonathan Bush | Operating Grant | 2021 | 2021 | Dr. Donald B. Rix Pathology & Laboratory Medicine Research Grant. 01/11/2021. | Immune Cell Profiling in Transcriptome-Defined SMARCB1 and SMARCA4-Deficient Pediatric Tumors | Jonathan Bush | $50,000 | |
| Joshua Dubland | Other (development grants) Grant | 2019 | 2023 | BC Children’s Hospital Research Instiitute - Clinical Research Support Unit | Next generation urine metabolic profiling for the diagnosis and monitoring of inborn errors of metabolism. | Bojana Rakic | Graham Sinclair; Joshua A. Dubland; Ramona Salvarinova-Zivkovic | $25,000 |
| Joshua Dubland | Other (development grants) Grant | 2021 | 2023 | BC Children's Hospital - Dr. Donald. B. Rix and Laboratory Medicine Research Fund | Immune Cell Profiling in Transcriptome-Defined SMARCB1 and SMARCA4-Deficient Pediatric Tumors. | Jonathan Bush | Christopher Dunham; Keegan Korthauer; Stephen Yip; Joshua A. Dubland | 50,000 |
| Joshua Dubland | Emerging Team Grant | 2021 | 2023 | BC Children's Hospital, Childhood Diseases 2021 Seed Grant | Novel Mass Spectrometry Based Spatial-Omics: Investigation into the Micro-Environment of Pediatric Wilms Tumours. | Jonathan Bush & Joshua A. Dubland | Bojana Rakic; Graham Sinclair; Jefferson Terry; Philipp Lange; Seth Parker | 30,000 |
| Karen Lam | Operating Grant | 2018 | 2023 | Canadian Institutes of Health Research (CIHR) | HEARTBiT: A novel multi-marker blood test for management of acute cardiac allograft rejection, Grant, Operating Clinical Research Project?: Yes | Bruce McManus | Karen Lam | 2,185,000 (CAD) |
| Karla Bretherick | Other (development grants) Grant | 2021 | 2024 | Dr. Donald B. Rix Pathology & Laboratory Medicine Research Grant | Assessing the feasibility of implementing non-invasive genetic diagnosis (NIPD) in the Division of Genome Diagnostics | Dr. Lindsay Brown | Dr Tanya Nelson, Dr Christine Tyson, Dr Emma Strong, Dr Karla Bretherick | $50 000 |
| Katherine Chipperfield | Operating Grant | 2019 | Present | BC Clinical Support Unit and Michael Smith Foundation | Supporting Patient participation in pediatric and pregnancy reference interval studies for safe medicine (P2RISM) | Vilte Barakauskas | Kate Chipperfield, Catherine Leung, Karla Muyzers | 19,997 |
| Kevin Bennewith | Operating Grant | 2019 | 2021 | Cancer Research Society | The influence of eosinophils and B cells on metastatic tumour growth in the lungs | Kevin Bennewith | Kelly McNagny (10%) | $60,000/yr |
| Kevin Bennewith | Operating Grant | 2020 | 2022 | Cancer Research Society | Granzyme B: a novel target for the treatment of radiodermatitis | David Granville | Kevin Bennewith (15%) | 60,000 |
| Kevin Bennewith | Operating Grant | 2018 | 2023 | Canadian Institutes of Health Research (CIHR) | Hypoxia in tumour-draining lymph nodes as an indication of immune activation and immunotherapy response | Kevin Bennewith | Ninan Abraham (10%) | $191,250/yr |
| Kevin Bennewith | Operating Grant | 2020 | 2023 | Varian Research Grant | Immunomodulatory effects of prostate brachytherapy | Mira Keyes | Kevin Bennewith (10%), Julian Lum, Srinivas Raman | 50,000 |
| Kevin Bennewith | Operating Grant | 2021 | 2026 | Canadian Institutes of Health Research (CIHR) | Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers | Kevin Bennewith | Pascal Bernatchez (5%) | 195,840 |
| Lenka Allan | Group Grant | 2018 | 2022 | Genome Canada | Precision Medicine CanPrevent Antibody Mediated Rejection | Dr. Paul Keown | Dr. Ruth Sapir-Pichhadze | 9 640 000.00 |
| Li Wang | Operating Grant | 2020 | 2021 | Childhood diseases seed grant 2020 BCCHRI | "Evaluating the Heterogeneity of T Cell Phenotypes in Pediatric Renal Transplant Recipients: Associations with Patient and Transplant Factors, and Alloimmune Activity” | Dr. Tom Blydt-Hansen | Dr. Li Wang | $30,000 |
| Li Wang | Operating Grant | 2020 | 2023 | Dr. Donald B. Rix and Laboratory Medicine Research Grant Department of Pathology | “A study of whether selectively ordering peanut component resolved diagnostics increases diagnostic accuracy in children in a cost-effective manner" | Dr. Li Wang | Dr. Edmond Chan | $34,500 |
| Lik Hang Lee | Other (development grants) Grant | 2019 | Present | VCH and PHC Physician-Led Quality Improvement - Doctors of BC | Biomarker Quality Framework | Lik Hang Lee | 25000 | |
| Linda Hoang | Operating Grant | 2020 | 2021 | CIHR | Rapid response to emerging serious pathogen outbreaks using Next-gen Data: R2ESPOND | Mel Krajden | Linda Hoang, Inna Sekirov, David Patrick, Naveed Janjua, Danuta Skowronski, Natalie Prystajecky, Richard Harrigan, William Hsiao, Christopher Fjell, Caroline Colijn | $25,000 |
| Linda Hoang | Operating Grant | 2019 | 2022 | Genome Canada | Unified pathogen control onehealth approach specifically targeting vibrio (UPCOAST-V) | Linda Hoang | Katie Eloranta | $498,010 |
| Linda Hoang | Operating Grant | 2020 | 2022 | CIHR | Rapid response to emerging serious pathogen outbreaks using Next-gen Data: R2ESPOND | Mel Krajden | Linda Hoang, Inna Sekirov, David Patrick, Naveed Janjua, Danuta Skowronski, Natalie Prystajecky, Richard Harrigan, William Hsiao, Christopher Fjell, Caroline Colijn | $1,000,000 |
| Linda Hoang | Operating Grant | 2021 | 2022 | Genome BC | COVID-19 Sequencing and Modelling Integrated with Laboratory and Epidemiological Sources (SMILES) | Agatha Jassem | Linda Hoang, Inna Sekirov, Naveed Janjua, Danuta Skowronski, Natalie Prystajecky, Michael Otterstatter, Manish Sadarangani, Hind Sbihi, Paul Tupper, John Tyson, Chris Fjell, Caroline Colijn, Paul Levett | $200,000 |
| Linda Hoang | Operating Grant | 2021 | 2022 | BCCDC Foundation | Vaccine Investigation of Transmission Analysis Longitudinally – Effectiveness (VITAL-E) | Catherine Hogan | Naveed Janjua, Michael Irvine, Hind Sbihi, Linda Hoang | $200,000 |
| Linda Hoang | Operating Grant | 2018 | 2023 | Genome BC | Bioinformatics tools to enable federated, real time genomic epidemiology data sharing and analysis in a one health framework | William Hsiao | Chelsea Himsworth, Linda Hoang, Eleni Galanis, Danuta Skowronski, Natalie Prystajecky, Agatha Jassem, Joao Andre Carrico, Tomy Joseph, Erin Fraser, Fiona Brinkman, Nancy De With, Gary Van Domselaar | $540,675.45 |
| Linda Hoang | Operating Grant | 2019 | 2023 | Genome Canada | PeptAid – Antimicrobial Peptides to Replace Antibiotics in Farm Veterinary Practice | Inanc Birol | Caren Helbing, Fraser Hof, Linda Hoang, Robin Coope, Erin Fraser, David Silver, Richard Barichello, Sarah Lee, Siyun Wang | $6,887,627 |
| Linda Hoang | Operating Grant | 2020 | 2023 | Genome BC | PeptAid antimicrobial peptides to replace antibiotics in farm veterinary practice | Erin Fraser | Richard Barichello, Linda Hoang, David Silver, Fraser Hof, Inanc Birol, Robin Coope, Caren Helbing, Sarah Jane Lee | $325,285 |
| Linda Hoang | Operating Grant | 2021 | 2024 | CIHR | Secondary Household Attack Rate Evaluation of COVID-19 (SHARE-COVID) | Danuta Skowronski | Manish Sadarangani, Linda Hoang, Mel Krajden, Inna Sekirov, Mayank Singal, Muhammad Morshed, Natalie Prystajecky, Agatha Jassem, Cecile Tremblay, Guy Boivin, Soren Gantt, Gaston De Serres | $53,308 |
| Linda Hoang | Operating Grant | 2021 | 2024 | CIHR | Teasing apart the differential impact of variants of concern on COVID-19 severity and health inequities: a population-based genomic epidemiological investigation in Ontario and British Columbia | Hind Sbihi | Catherine Hogan, Linda Hoang, Mel Krajden, Eleni Galanis, Inna Sekirov, Caren Rose, Naveed Janjua, Natalie Prystajecky, Agatha Jassem, et al. | $451,188 |
| Linda Hoang | Operating Grant | 2019 | Present | Genome BC: GeneSolve Program | Stakeholders Targeting Emerging Anti-Microbial Resistant Organisms to Learn Lessons and Evaluate Response (STEAMROLLER) | 88,000 | ||
| Lindsay Brown | Operating Grant | 2019 | 2021 | Childhood Diseases Next Step Grant competition | Clinical validation of next generation sequencing | Dr Tanya Nelson | Dr(s) L Brown, C Tyson, B. Coe, Dr A. Matthews | $25,000 |
| Lindsay Brown | Operating Grant | 2020 | 2022 | BC Children’s Hospital Pathology & Lab Medicine Seed grant | Holoprosencephaly and White Matter Stroke | Dr Chris Dunham | Dr(s) Lindsay Brown, Sarah Nikkel, Jessica Saunders, Sumit Das | $10,000 |
| Lindsay Brown | Operating Grant | 2021 | 2024 | Dr. Donald B. Rix Pathology & Laboratory Medicine Research Grant | Assessing the feasibility of implementing non-invasive prenatal genetic diagnosis (NIPD) in the Division of Genome Diagnostics. | Dr Lindsay Brown | Dr(s) Tanya Nelson, Emma Strong, Karla Bretherick, Christine Tyson, Sylvie Langlois, Hillary Vallance and Kim Seath | $49,862 |
| Lucy Perrone | Other (development grants) Grant | 2016 | 2021 | US Centers for Disease Control and Prevention (PEPFAR) | Strengthening leadership and quality management systems for improved and sustainable diagnostics network in Cote d’Ivoire. | Lucy Perrone | 10,811,162 | |
| Lucy Perrone | Other (development grants) Grant | 2020 | 2023 | US Department of Defense, Defense Threat Reduction Agency | Countering Especially Dangerous Pathogen Threats in Ukraine- developing a national cadre of Biological Threat Reduction Program (BTRP) instructors for the Ministry of Health in Ukraine | Lucy Perrone | 1,151,498 | |
| Lucy Perrone | Other (development grants) Grant | 2021 | 2026 | US Centers for Disease Control and Prevention (PEPFAR) | Building Sustainable Health Systems and Laboratory Services in Cote d’Ivoire under the President’s Emergency Plan for AIDS Relief (PEPFAR). | Lucy Perrone | 395,000 | |
| Majid Zolein | Under Review | 2021 | Present | INTERIOR HEALTH | Lymphocytosis and non-Hodgkin Lymphoma in patients receiving long-term therapy for anxiety/depression and psychosis | Myself | Barbara Buckley Jason Curran | |
| Marc Romney | Operating Grant | 2021 | 2021 | Providence Health Care Research Institute | Advancing real-time SARS-CoV-2 genomic analyses to enable rapid action in healthcare-related SARS-CoV-2 outbreaks | Lowe C | Brumme C (co-PI), Brumme Z, Joy J, Leung V, Matic N, Ritchie G, Romney M | $7,000 |
| Marc Romney | Operating Grant | 2020 | 2022 | Public Health Agency of Canada and COVID-19 Immunity Task Force | Integrating longitudinal epidemiologic, virologic and immunologic analyses to understand COVID-19 immunity and infection outcomes in long term care | Romney M | Brockman M (co-PI), Brumme Z(co-PI), Brumme C, Harding J, Choy J, DeMarco M, Joy J, Lowe C, Leung V, Matic N, Montaner J, Niikura M, Ritchie G | $1,199,680 |
| Marcel Bally | Operating Grant | 2016 | 2021 | Canadian Institutes of Health Research | The biology and clinical significance of the tumour microenvironment in B cell lymphomas | C. Steidl | M. Bally, A. Weng, G. Slack, S. Shah, K. Savage, G. Morin | 1,538,008 |
| Marcel Bally | Operating Grant | 2017 | 2021 | Canadian Institutes of Health Research | Copper Drug Complexes: Development of a novel class drugs with significant potential for treatment of platinum insensitive cancers | M. Bally | 122,400 | |
| Marcel Bally | Operating Grant | 2019 | 2021 | Nanomedicines Innovation Network | Development of the Metaplex Immuno-Oncology Platform | M. Bally | B. Nelson | 250,000 |
| Marcel Bally | Operating Grant | 2019 | 2021 | Nanomedicines Innovation Network | PharmaCore - Preclinical Scale-up Manufacturing and Project Management Core Facility | M. Bally | S-D. Li, N. Dos Santos | 170,000 |
| Marcel Bally | Operating Grant | 2020 | 2021 | Nanomedicines Innovation Network | Development of an aerosolized liposomal hydroxychloroquine for treating COVID-19 patients entering hospitals | M. Bally | 50000 | |
| Marcel Bally | Operating Grant | 2019 | 2021 | Nanomedicines Innovation Network | A platform to screen for upregulation of soluble calreticulin as a tool to develop nanomedicines targeting acute myeloid leukemia | G. Walker | S. Zou, M. Bally, M. Nitz | 22500 |
| Marcel Bally | Operating Grant | 2017 | 2022 | Canada foundation for Innovation | Accelerated Drug Discovery Using Clinical Translation (ADDUCT) | A. Cherkasov | M. Bally, K. Chi, C. Collins, M. Daugaard, M. Gleave, L. McIntosh, P. Rennie, N. Strynadka, Y. Wang | 9,049,486 |
| Marcel Bally | Operating Grant | 2019 | 2023 | National Centre of Excellence | NanoMedicines Innovation Network (NMIN) | P. Cullis | M. Bally, C. Allen, S. Kelly, G. Walker | 18,532,000 |
| Marcel Bally | Operating Grant | 2021 | Present | Canadian Institutes of Health Research | A Novel Formulation of the Anticancer Drug Candidate CX5461 that Relies on Metal Chemistry and Liposomal Nanotechnology: Development for use in Treatment of Pancreatic Cancer's with BRCA Deficiencies; an Orphan Indication | M. Bally | D. Renouf | 765,000 |
| Mari DeMarco | Operating Grant | 2018 | 2021 | Brain Canada | Translating research into practice: Investigating the impact of Alzheimer's disease diagnostics in Canada (IMPACT-AD) | DeMarco ML | $739,459 | |
| Mari DeMarco | Operating Grant | 2020 | 2021 | CIHR - Priority Announcement for Neurosciences, Mental Health and Addiction | Diagnostic and predictive biomarkers for frontotemporal dementia with TDP-43 pathology | DeMarco ML | $100,000 CAD | |
| Mari DeMarco | Operating Grant | 2015 | 2022 | Canadian Institutes of Health Research | Using Multi-Omics To Discover Novel Biomarkers and Therapeutic Targets for COPD | Sin D | CoI: DeMarco ML | $2,250,000 |
| Mari DeMarco | Operating Grant | 2017 | 2022 | Michael Smith Foundation for Health Research, Scholar Award | Advancing Healthcare Diagnostics for Neurodegenerative Disorders | DeMarco ML | $450,000 | |
| Mari DeMarco | Operating Grant | 2017 | 2022 | Canadian Foundation for Innovation | TORCH (Towards Omics and imaging to Revolutionize COPD and asthma Health) in Canada | Sin D | DeMarco ML | $5,516,000 |
| Mari DeMarco | Operating Grant | 2020 | 2022 | Michael Smith Foundation for Health Research - Innovation to Commercialization | Biomarker tests to diagnose and prognose acute exacerbations of chronic obstructive pulmonary disease | DeMarco ML (lead for blood test assay development) | $300,000 CAD | |
| Maria Issa | Other (development grants) Grant | 2019 | 2023 | WAGE - Ministry for Women and Gender Equality, Canada | SCALE - SCWIST Connects, Advocates and Leverages Expertise - to expand STEM diversity for economic empowerment across Canada. | Dr. Maria Issa | Cheryl Kristiansen, P.Eng | 997,000 |
| Marianne Sadar | Operating Grant | 2014 | 2022 | BC Cancer Foundation | Harold Mahood Prostate Cancer Research Fund (over 5 years) | M.Sadar | $2,900,000 | |
| Marianne Sadar | Operating Grant | 2017 | 2023 | National Institutes of Health /NCI (USA | Delineating the mechanism of androgen receptor activation function-1 antagonists for development of novel prostate cancer therapeutics. | M. Sadar | Co-applicant: R. Andersen | US$1,353,206 |
| Marianne Sadar | Operating Grant | 2021 | 2026 | NCI/NIH (USA) | Structure, function, and application of novel antagonists of the intrinsically disordered androgen receptor amino-terminal domain as imaging agents and therapeutics | M.Sadar | R. Andersen, N. Strynadka, K-S. Lin | US $2,139,345 (~Cdn $3,390,000) |
| Mark Scott | Operating Grant | 2019 | 2022 | Collaborative Health Research Projects (CHRP) | CHRP xxxx: Deformability based Cell Sorting Enabling Quality Control of Stored Red Blood Cells | Dr. Hongshen Ma | Dr. Mark D. Scott | $806,998 (3 years) |
| Martin Wale | Group Grant | 2017 | 2022 | Private donor, through Victoria Hospitals Foundation | Vancouver Island Cognitive Health initiative | Scott Hofer | Andrew Penn, Alex Henri-Bhargava | $2.5m |
| Matthew Tak Sheng Yan | Other (education innovation) Grant | 2020 | 2021 | Canadian Blood Services BloodTechNet Award | Blood and stem cell donation for men who have sex with men in Canada: A toolkit for healthcare professionals | Warren Fingrut | 20000 | |
| Matthew Tak Sheng Yan | Operating Grant | 2020 | 2021 | Canadian Institutes of Health Research | CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) | Donald Arnold | Jeannie Callum, Philippe Begin | 2972000 |
| Matthew Tak Sheng Yan | Other (education innovation) Grant | 2021 | 2022 | Canadian Blood Services BloodTechNet Award | An interactive virtual tour of blood product manufacturing at Canadian Blood Services | Melanie Bodnar | Matthew Yan, Sophie Charge, Bryan Tordon, Tricia Abe, Gwen Clarke | 20000 |
| Matthew Tak Sheng Yan | Under Review | 2021 | Present | Canadian Institutes of Health Research | Four-Factor Prothrombin Complex Concentrate Versus Frozen Plasma in Bleeding Adult Cardiac Surgical Patients: A multicentre randomized controlled trial (FARES-II) | Keyvan Karkouti | Jeannie Callum | 1415000 |
| Matthew Tak Sheng Yan | Operating Grant | 2020 | Present | Canadian Blood Services Blood Efficiency Accelerator Program | A study to understand C1 esterase inhibitor distribution and use patterns in Canada | Donald Arnold | Matthew Yan, Andrew Shih, Douglas Morrison, Nancy Heddle, Shuoyan Ning, Susan Wasserman, Kathryn Webert | 29858 |
| Mei Lin Z. Bissonnette | Group Grant | 2017 | 2022 | Transplant Research Foundation of British Columbia | Immunosuppression Reduction and the Risk of De Novo Donor-Specific Antibody Formation After Kidney Transplantation | James Lan | Paul Keown, John Gill, Jag Gill, Olwyn Johnston, Mei Lin Bissonnette | 50,000 |
| Mel Krajden | Team Grant | 2018 | 2021 | CIHR | Achieving hepatitis C elimination in Canada; addressing the needs of the diverse groups at risk | Christina Greenaway, Naveed Janjua, Jeffrey Kwong, Beate Sander | L. Azoulay, MK. Blouin, J. Bruneau, M. Dickie, J. Feld, M. Krahn, M. Krajden, L. Lapointe-Shaw, D. Murphy, M. Otterstatter, R. Platt, E. Pullenayegum, H. Samji, M. Tyndall, B. Warshawsky, W. Wong | $1,197,225 |
| Mel Krajden | Team Grant | 2018 | 2021 | CIHR | A Precision Public Health Approach to Eliminating Tuberculosis Transmission: Using Linked Genomic and Administrative Data to Prevent Outbreaks | Jennifer Leigh Gardy, James Cameron Johnston | V. Cook, N. Janjua, M. Krajden, C. Rose | $180,000 |
| Mel Krajden | Operating Grant | 2019 | 2021 | WHRI | Defining the Hepatitis C (HCV) Cascade of care for pregnant women and their infants | Laura Sauvé | D. Goldfarb, R. Schreiber, N. Pick, C. Elwood, M. Pearce, M. Krajden, N. Janjua | 25000 |
| Mel Krajden | Operating Grant | 2020 | 2021 | Genome BC | Responding to Emerging Serious Pathogen Outbreaks using Next-gen Data: RESPOND | Mel Krajden | R. Harrigan, N. Prystajecky | 150000 |
| Mel Krajden | Operating Grant | 2020 | 2021 | Genome Canada | SAfER BC | Simon Pimstone, Mel Krajden, Josef Penninger, Tania Bubela | 1110000 | |
| Mel Krajden | Team Grant | 2015 | 2022 | CIHR | Integrated global control and prevention of HPV related diseases and cancer. | Gina Ogilvie | C. Biryabarema, J. Byamugisha, J. Christilaw, A. Coldman, S. Dobson, M. Gilbert, B. Henry, M. Krajden, M. Lee, M. Lusti-Narasimhan, C. Mclachlin, D. Miller, D. Money, M. Naus, S. Peacock, H. Pedersen, V. Russell, M. Saraiya, M. Sekikubo, J. singer, G. Stuart | $387,785 |
| Mel Krajden | Team Grant | 2017 | 2022 | CIHR | Understanding contextual factors to effectively and equitably scale up GetCheckedOnline to diverse populations and geographic settings | Mark Gilbert, Ryan Lisk, Gina McGowan, Daniel Grace and Catherine Worthington | A. Ablona, D. Brennan, S. Bryan, A. Burchell, S. Chown, D. Coombs, D. Cyr, A. Derban, J. Duddy, C. Estcourt, C. Fairley, T. Falasinnu, P. Flowers, M. Gale-Rowe, J. Grennan, O. Gómez Ramírez, D. Haag, B. Hawkins, D. Hoyano, F. Ibanez-Carrasco, M. Irvine, J. Jollimore, T. Kerr, K. Kinakin, R. Knight, M. Krajden, N. Lachowsky, E. Lim, T. Mazzulli, Dr. S. Mema, Dr. S. Mishra, Dr. D. Moore, M. Murti, E. Mykhalovskiy, G. Ogilvie, E. Ratnarajah, T. Salway, N. Saraf, K. Shannon, J. Shoveller, D. Taylor, F. Webster, J. Wong | $400,000 |
| Mel Krajden | Operating Grant | 2019 | 2022 | CIHR | The impact of chronic/latent viral infections on aging | Helene Cote | M. Krajden, M. Murray | 150000 |
| Mel Krajden | Infrastructure Grant | 2016 | 2022 | Canada Foundation For Innovation | High-performance computing for rapid-response infectious disease genomic epidemiology | Mel Krajden | 48800 | |
| Mel Krajden | Operating Grant | 2020 | 2022 | CIHR | Rapid Response to Emerging Serious Pathogen Outbreaks using Next-gen Data: R2ESPOND | Natalie Prystajecky | R. Harrigan, M. Krajden | 1000000 |
| Mel Krajden | Team Grant | 2018 | 2023 | CIHR | What will it take to decrease the burden of the HIV and STI epidemics among MSM in British Columbia, Canada? A sexual network modeling analysis, combining syndemic theory, to evaluate the impact of behavioural and biomedical interventions for HIV and STI prevention | Viviane Lima | R. Barrios, M. Gilbert, R. Hogg, M. Hull, M. Krajden, N. Lachowsky, J. Montaner, D. Moore, T. Patterson, C. Richardson, I. Rozada, J. Shoveller, M. St-Jean, J. Wong | $810,900 |
| Mel Krajden | Team Grant | 2012 | 2024 | Michael Smith Foundation for Health Research | Quadrivalent vaccine evaluation study (QUEST) | Gina Ogilvie | Simon Dobson, Joel Singer, Marie Helene Mayrand, Shelly McNeil, Francois Coutlee, Mel Krajden | $2,200,00 |
| Michael Allard | Operating Grant | 2020 | 2022 | TD Ready Challenge Application | UBC's Remote Communities Drone Transport Initiative (DTI) - Enhancing Equity of Access to Health Services by Use of Bidirectional Unmanned Aerial Vehicle | Dr. Mike Allard | Dr. Nadine Caron, Dr. Nancy Humber, Dave Kang, Dr. Larry Lynd, John Mah, Dr. Ray Markham, Dr. Shannon McDonald, Dr. Gina Ogilvie, Dr. John Pawlovich, Dr. Rob Petrella, Ed Ratnarajah, Daniel Tham, Dr. Peter Zed, Michael Zahra | $636,800.00 |
| Michael Seidman | Operating Grant | 2018 | 2023 | CIHR | Relative deficiency of lysosomal acid lipase in arterial smooth muscle cells as a novel target for atherosclerosis treatment and prevention | Gordon Francis | 512,550 | |
| Michael Seidman | Operating Grant | 2018 | 2023 | CIHR | The role of endothelial function in the pathogenesis and management of Marfan syndrome-associated aortic disease | Pascal Bernatchez | Mitra Esfandiarei, Kevin Harris, James Potts, George Sandor, Cornelius Van Breemen | 669,376 |
| Muhammad Morshed | Operating Grant | 2020 | 2021 | Michael Smith Foundation for Health Reasearch | Accelerating SARS-CoV-2 SEroprevalence SurveyS through Dried Blood Spots (ASSESS-DBS) | Muhammad Morshed | Christian Schutz, Inna Sekirov, Paul Levett, Patricia Spittal | 150,000 |
| Muhammad Morshed | Operating Grant | 2020 | 2021 | Genome British Columbia. Genome BC Rapid Response Funding for COVID-19 Research and Innovation Projects | Characterizing Antibody Response to Emerging COVID-19 Virus (CARE COVID-19) | Muhammad Morshed | Inna Sekirov, Agatha Jassem; Althea Hayden; Shazia Masud | 250,000 |
| Muhammad Morshed | Team Grant | 2019 | 2022 | CIHR | A national research network on Lyme disease, 2019-2022, CAD$:3,990,966.00 | Kieren Moore | M. Morshed + 15 others | 3,990,966.00 |
| Muhammad Morshed | Operating Grant | 2021 | 2023 | Public Health Agency of Canada | Prospective Cohort Study to Examine Immunogenicity of SARS-CoV-2 Vaccination in Cancer Patients with Solid Malignancies | Glenn Goss | Stephen Chia, Carolina Ilkow, Diane Lu, Muhammad Morshed, Tim Ramsay, Manish Sadarangani, Inna Sekirov, Theodore Steiner | 1,865,167 |
| Muhammad Morshed | Operating Grant | 2021 | 2023 | Canadian Immunity Task Force | The PREVENT-COVID in Seniors Study: PRospEctiVe EvaluatioN of immunity after COVID-19 vaccines in Seniors | Agatha Jassem, Manish Sadarangani | Muhammad Morshed, Mel Krajden, Danuta Skowronski, James Zlosnik, Sofia Bartlet, Citali Marquez | 1,930,600 |
| Muhammad Morshed | Operating Grant | 2020 | 2023 | CIHR | Operating Grant: COVID-19 Rapid Research | CL Tremblay | Muhammad Morshed | 859,485 |
| Muhammad Morshed | Operating Grant | 1999 | Present | Lyme Disease Association of Ontario | Study of Lyme disease in Ontario | M. Morshed | $3000 per year | 36000 |
| Nancy Matic | Other (education innovation) Grant | 2020 | 2021 | Genome British Columbia | Development of sensitive and quantitative molecular technologies for SARS-CoV-2 detection | Dr. Christopher Lowe, Dr. Zabrina Brumme | Dr. Chanson Brumme, Dr. Nancy Matic, Dr. Julio Montaner, Dr. Gordon Ritchie, Dr. Marc Romney, Dr. Aleksandra Stefanovic | $101,000 |
| Nancy Matic | Other (education innovation) Grant | 2020 | 2021 | Faculty of Medicine, University of British Columbia | New Faculty Research Award, Funding awarded for "Cytomegalovirus (CMV) antiviral resistance genotyping using real-time amplification and next-generation sequencing" | Dr. Nancy Matic | Dr. Christopher Lowe, Dr. Gordon Ritchie, Dr. Marc Romney | $10,000 |
| Nancy Matic | Other (education innovation) Grant | 2020 | 2022 | COVID-19 Immunity Task Force | Integrating longitudinal epidemiologic, virologic, and immunologic analyses to understand COVID-19 immunity and infection outcomes in long term care | Dr. Marc Romney, Dr. Zabrina Brumme, Dr. Mark Brockman | Chanson Brumme, Jonathan Choy, Jeffrey Joy, Christopher Lowe, Victor Leung, Mari DeMarco, Nancy Matic, Julio Montaner, Masa Niikura, Gordon Ritchie | $1,200,000 |
| Nancy Matic | Other (education innovation) Grant | 2020 | Present | Providence Health Care Research Institute | Advancing real-time SARS-CoV-2 genomic analyses to enable rapid action in healthcare-related SARS-CoV-2 outbreaks | Chanson Brumme, Christopher Lowe | Zabrina Brumme, Jeffrey Joy, Victor Leung, Nancy Matic, Gordon Ritche, Marc Romney | $7,000 |
| Natalie Prystajecky | Operating Grant | 2020 | 2021 | CIHR | Household transmission of SARS-CoV-2 | Cecile Tremblay, Danuta Skowronski, Guy Boivin, De Serres | Soren Gantt, Mel Krajden, Linda Hoang, Agatha Jassem, Natalie Prystajecky, Inna Sekiorv, Mohammad Morshed, M. Sadarangan, M. Singal | 859, 485 |
| Natalie Prystajecky | Operating Grant | 2020 | 2021 | NSERC | COVID-19 in wastewater | Ryan Ziels and Natalie Prystajecky | 50,000 | |
| Natalie Prystajecky | Operating Grant | 2020 | 2021 | MSFHR | Phylodynamics of SARS-CoV-2 | Caroline Colijn | Richard Harrigan, Anders Goncalves da Silva, Natalie Prystajecky, Linda Hoang | 150,000 |
| Natalie Prystajecky | Operating Grant | 2019 | 2021 | Genome BC | Norovirus genomics in humans and oysters | Natalie Prystajecky | P. Levett | 500,000 |
| Natalie Prystajecky | Operating Grant | 2021 | 2021 | Genome British Columbia | One Health Genomics for the COVID-19 Pandemic: The Mink Problem | Natalie Prystajecky | Chelsea Himsworth | 250,000 |
| Natalie Prystajecky | Operating Grant | 2020 | 2022 | CIHR | Gender and COVID-19: ACE-II | Natalie Prystajecky | William Gibson, Inna Sekirov | 50,000 |
| Natalie Prystajecky | Operating Grant | 2020 | 2022 | CIHR | SARS-CoV-2 Genomics | Natalie Prystajecky, Mel Krajden | Richard Harrigan, Naveed Janjua, Chris Fjell, Linda Hoang, Danuta Skowronski, David Patrick | 1,000,000 |
| Natalie Prystajecky | Operating Grant | 2020 | 2023 | CFI | COVID testing | Marco Marra | Martin Hirst, Robin Coope, Natalie Prystajecky, | 377,738 |
| Natalie Prystajecky | Operating Grant | 2020 | 2023 | CFI | COVID genomics | Mel Krajden | Natalie Prystajecky, Inna Sekirov, Agatha Jassem, Anders Goncalves da Silva | 630,000 |
| Niamh Kelly | Emerging Team Grant | 2016 | Present | SSHRC | Pipelines and the poetics of place | Steven Taubeneck | Nigel Haggan, NIamh Kelly and others | $30,000 |
| Nicholas Au | Operating Grant | 2020 | Present | BCCHR (Dr. Donald B. Rix and Lab Medicine Grant) | Platelet functional investigation by flow cytometry: determination of clinical utility and pediatric platelet function | Dr. Nicholas Au | Dr. S. Vercauteren Dr. M. Belletrutti Dr. S. Jackson | $50,000 |
| Peter Chow-White | Operating Grant | 2018 | Present | Genome BC and Genome Canada Large Scale Applied Research Project – Genomics and Precision Health | Genomic Outcomes Databank for Pharmacogenomic and Implementation Studies (Go PGx). | Bruce Carleton | Peter Chow-White (GE3LS Advisor) | $2,749,021.00 |
| Peter Chow-White | Operating Grant | 2017 | Present | Greenwell Foundation | Developing best practices for medical crowdfunding. | Peter Chow-White, Jeremy Snyder, Valorie Crooks | $47,688 | |
| Peter Chow-White | Operating Grant | 2017 | Present | SSHRC and Genome Canada | Big data collaborative networks: The role of communication in the development of genomic technologies. | Peter Chow-White | $179,340 | |
| Peter Schubert | Equipment Grant | 2020 | 2022 | TerumoBCT, Lakewood, CO, USA | In vitro quality determination of cold-stored leukoreduced whole blood collected in CPDA-1 anticoagulant | Peter Schubert | ||
| Peter Van den Elzen | Operating Grant | 2018 | 2021 | MS Society of Canada | The role of EBV, B cells and NKT cells in MS | Peter van den Elzen | Soren Gantt | $316,500 |
| Peter Watson | Infrastructure Grant | 2016 | 2021 | TFRI | CTRNet | Watson | $100,000 | |
| Peter Watson | Team Grant | 2018 | 2021 | Glyconet | Atypical glycan based liquid biopsy for rsik stratification in early breast cancer | Karla Williams | Peter Watson | $88,464 |
| Peter Watson | Other (development grants) Grant | 2020 | 2021 | UBC Faculty of Medicine Strategic Innovation Fund | COVID-19: interdisciplinary clinical care network and research platform | Ryerson | Watson, Palepu, Knight, Calrsten, Johnston | $300,000 |
| Philipp Lange | Team Grant | 2017 | 2021 | Michael Cuccione Childhood Cancer Foundation | BRAvE Research Initiative | Philipp Lange, Chris Maxwell, Gregor Reid, James Lim | $900,000 | |
| Philipp Lange | Operating Grant | 2020 | 2021 | CIHR Priority Announcement | Project Grant - PA: Prize: Early Career Investigator in Cancer | Philipp Lange | $25,000 | |
| Philipp Lange | Salary Support | 2017 | 2022 | MSFHR - Michael Smith Foundation for Health Research | Translational Proteomics and Systems Biology of Childhood Cancer | Philipp Lange | $450,000 | |
| Philipp Lange | Operating Grant | 2019 | 2022 | Terry Fox Research Institutes | Terry Fox PROFYLE - Proteomics in Pediatric Precision Oncology | Philipp Lange | $70,666 | |
| Philipp Lange | Team Grant | 2021 | 2022 | BC Children's Hospital Research Institute - CD Theme | Novel Mass Spectrometry Based Spatial-Omics: Investigation into the Micro-Environment of Pediatric Wilms Tumours | Jonathan Bush, Joshua Dubland | Philipp Lange, Seth Parker, Bojana Rakic, Graham Sinclair, Jefferson Terry | $30,000 |
| Philipp Lange | Team Grant | 2021 | 2022 | C17 Research Network | Hunt for therapeutic targets in Rhabdomyosarcoma: Comparative proteomics in cross-species model systems for precision diagnostics and rapid drug testing | Rebecca Gladdy | P Lange, M Hayes, J Berman, D Senger, J Chan, M Irwin, G Reid, C Maxwell, D Malkin, N Melong, G Morin, M Moran, P Sorensen, | 45,000 |
| Philipp Lange | Operating Grant | 2021 | 2023 | BC Children's Hospital Research Institute - Catalyst Grant | Maternal Serum Biomarkers of Amniotic Fluid Infection/Inflammation Syndrome | Philipp Lange | Jefferson Terry | $39,240 |
| Philipp Lange | Operating Grant | 2018 | 2024 | Canada Foundation for Innovation | CFI Infrastructure Operating Fund | Philipp Lange | $37,500 | |
| Philipp Lange | Operating Grant | 2018 | 2024 | NSERC Discovery Grant | Bioinformatics resources for genome wide assessment of protein function at the proteoform level | Philipp Lange | $180,000 | |
| Philipp Lange | Salary Support | 2020 | 2025 | BC Children's Hospital Research Institute | BCCHRI Investigator Grant Award Program | Philipp Lange | $300,000 | |
| Philipp Lange | Operating Grant | 2020 | 2025 | CIHR Project Grant | Tumour microenvironment mediated cell surface shedding creates unique targets and markers | Philipp Lange | $952,425 | |
| Philipp Lange | Salary Support | 2020 | 2025 | CIHR / Canada Research Chairs | Canada Research Chair (Tier II) in Translational Proteomics of Pediatric Malignancies | Philipp Lange | $500,000 | |
| Philipp Lange | Operating Grant | 2021 | 2026 | CIHR Project Grant | Investigating the Adamts19-dependent mechanisms that regulate valve maturation | Gregor Andelfinger | Philipp Lange, Antonio Nanci | $1,086,300 |
| Philipp Lange | Operating Grant | 2021 | 2026 | CIHR Project Grant | Targeting CD47 in pediatric acute lymphoblastic leukemia | C James Lim | Philipp Lange, Christopher Maxwell | 1,028,925 |
| Philipp Lange | Team Grant | 2021 | 2026 | Michael Cuccione Childhood Cancer Foundation | BRAvE Research Initative | Philipp Lange, Chris Maxwell, Gregor Reid, James Lim | $2,000,000 | |
| Poul Sorensen | Infrastructure Grant | 2020 | 2021 | The University of British Columbia | Building ultracentrifugation capacity in the BCCRI to support cutting-edge proteomics initiatives | P Sorensen, G Morin, K Hay | $88,912 | |
| Poul Sorensen | Operating Grant | 2015 | 2022 | Canadian Institutes of Health Research (CIHR) | Targeting the tumour cell stress response in high-risk childhood cancers (2014 Foundation Grant) | P Sorensen | Y Wang, M Taylor, P Sullivan, N Sonenberg, S Shah, J Pospisilik, M Marra, G Morrin | $2,335,402 |
| Poul Sorensen | Operating Grant | 2010 | 2022 | BC Cancer Foundation | Targeting Metastatic Disease in High Risk Childhood Cancer | P Sorensen | $3,498,857 | |
| Poul Sorensen | Team Grant | 2016 | 2022 | Terry Fox Research Institute (TFRI) | The Terry Fox New Frontiers Program Project Grant in Targeting the Adaptive Molecular Landscape in Castrate-Resistant Prostate Cancer | M Gleave | C Collins, Y Wang, A Zoubeidi, C Ong, R Buttyan, M Cox, K Chi, M Daugaard, E Gunns, A Cherkasov, A So, P Sorensen | $750,000 out of $7,440,000 |
| Poul Sorensen | Team Grant | 2017 | 2022 | St. Baldrick’s Foundation / American Association for Cancer Research / Stand Up To Cancer | Immunogenomics to Create New Therapies for High-Risk Childhood Cancers | J Maris, C Mackall | P Sorensen, others | USD$ 925,000 out of USD$ 15,000,000 |
| Poul Sorensen | Team Grant | 2019 | 2022 | American Association for Cancer Research International-Canada / Canadian Cancer Society (CCS) / Canadian Institutes of Health Research (CIHR) / Stand Up To Cancer Canada | Targeting mRNA translation to effectively treat metastatic breast cancer | N Sonenberg, M Pollak | S Aparicio, S Dedhar, C Eaves, K Gelmon, J Mackey, G Morin, B Nelson, M Park, L-M Postovit, S del Rincon, P Sorensen, I Topisirovic | $649,000 out of $6,000,000 |
| Poul Sorensen | Operating Grant | 2020 | 2022 | St. Baldrick’s Foundation- Pediatric Ewing Sarcoma | Novel approcahes to targeting Ewing Sacroma | P Sorensen | S Burdach, A Cherkasov, M Daugaard, DS Dimitrov | USD $390,550 out of USD $975,000 |
| Poul Sorensen | Operating Grant | 2020 | 2022 | Cura Placida Foundation | Endogenous retroelements: their role and therapeutic targeting in Ewing sarcoma | P Sorensen | S Burdach, L Stein | $25,000 out of $153,040 |
| Poul Sorensen | Operating Grant | 2020 | 2022 | Stand Up To Cancer / American Association for Cancer Research | Enhancing ferroptosis to block Ewing sarcoma metastatic capacity | P Sorensen | E Lawlor | USD $125,000 out of USD $250,000 |
| Poul Sorensen | Infrastructure Grant | 2021 | 2022 | The University of British Columbia | Molecular and Advanced Pathology Core (MAPcore): a Translational Research Core Platform for UBC | D Huntsman | D Schaffer, T Nielsen, B Gilks, L Hoang, A Bashashati, M Anglesio, A Talhouk, T Ng , S Yip, Sorensen P, Aparicio S, A El-Naggar, E Thompson | $160,000 |
| Poul Sorensen | Other (development grants) Grant | 2021 | 2022 | Stelexis | Effects of the Stelexis anti-IL1RAP antibody on cysteine and GSH metabolism, and ferroptosis induction in tumor cells | P Sorensen | USD$ 70,000 | |
| Poul Sorensen | Team Grant | 2016 | 2023 | TFRI | Precision Oncology for Young People (PROFYLE) | D Malkin | J Berman, J Chan, D Eisenstat, C Fernandez, M Irwin , N Jabado , R Ressekh, D Sinnett, P Sorensen, P Sullivan, M Taylor | $268,587 out of $12,876,466 |
| Poul Sorensen | Team Grant | 2018 | 2023 | National Institutes of Health | Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers | J Maris, C Mackall | N Ahmed, R Angelo, M Baker, K Davis, S Diskin, A Erbe, B Garcia, J Hank, M Hegde, K Kim, J Kuo, S Mack, G Morin, Z Morris, Y Mosse, M Mukherjee, M Porteus, A Rakhmilevich, A Resnick, P Sondel, P Sorensen, S Tasian | USD $1,534,328 out of USD$12,197,183 |
| Poul Sorensen | Team Grant | 2018 | 2025 | Terry Fox Research Institute (TFRI) | The Terry Fox New Frontiers Program Project Grant in New Vistas on Cancer Biology and Treatment: Conceptual Advancements from the Forme Fruste Project | D Huntsman | (all Principal Investigators) Aparicio S, Morin G, Bouchard-Cote A, Shah S, Hirst M, Lee C, Nielsen T, Sorensen PH, Underhill TM, Yip S | $1,045,669 out of $6,012,984 |
| Ramon Geltink | Operating Grant | 2020 | 2021 | BC Children's Hospital Research Institute, Childhood Diseases Theme, SEED Grant competition. | Metabolic Conditioning of Expanded Primary Human T cells for Adoptive Cellular Therapy. | Ramon. I. Klein Geltink | Suzanne Vercauteren | 30,000 |
| Ramon Geltink | Operating Grant | 2021 | 2022 | BC Children's Hospital Research Institute, Childhood Diseases Theme, SEED Grant competition. | Known and novel urinary biomarkers for the management of childhood autoimmune vasculitis. | Kelly Brown | Ramon I. Klein Geltink | 30,000 |
| Ramon Geltink | Team Grant | 2021 | 2024 | CIHR clinical translation team grant competition | Regulatory Natural Killer Cell Treatment in Chronic Graft-versus-Host Disease and Solid Organ Transplantation Chronic Rejection | Kirk Schultz | Ramon I. Klein Geltink Paul Keown | 750,000 |
| Ramon Geltink | Operating Grant | 2020 | 2025 | NSERC | Cell intrinsic regulation of central carbon metabolism in effector T cells | Ramon I. Klein Geltink | 162,500 | |
| Ramon Geltink | Operating Grant | 2021 | 2026 | Canadian Cancer Society - Early Scholar Award competition | Metabolic Conditioning of T cells for Immunotherapy of Cancer | Ramon I. Klein Geltink | 600,000 | |
| Ryan Morin | Operating Grant | 2019 | 2021 | ASH Foundation | Integrative genomic analysis of aggressive lymphomas | R Morin | 150,000 USD | |
| Ryan Morin | Team Grant | 2016 | 2021 | TFRI | Overcoming treatment failure in lymphoid cancers | M Marra, C Steidl, J Connors, D Scott, A Weng, R Morin, S Shah | 7,500,000 | |
| Ryan Morin | Training Grant | 2015 | 2021 | NSERC | Training Program In High-Dimensional Bioinformatics (HBD) | P Pavlidis | S Jones, R Morin, F Brinkman, J Bryan, N Chen, S Hallam, R Ng, W Wasserman | 1,650,000 (0 to Morin) |
| Ryan Morin | Salary Support | 2017 | 2022 | MSFHR | Studying genetic mechanisms of treatment resistance in non-Hodgkin Lymphomas | R Morin | 450,000 | |
| Ryan Morin | Operating Grant | 2018 | 2023 | CIHR | Optimizing immunotherapy in high-risk lymphoma | N Johnson | R Morin | 1,208,700 (150k) to Morin |
| Ryan Morin | Operating Grant | 2019 | 2024 | CIHR | Prioritization and functional characterization of regulatory mutations in non-Hodgkin lymphoma | R Morin | T Audas, P Unrau | 784,126 |
| Samuel Aparicio | Operating Grant | 2013 | 2021 | BCCA / BCCF | Breast cancer evolution and therapeutics program, Nan and Lorraine Robertson Chair in Breast Cancer Research | SA Aparicio | $1,950,000 | |
| Samuel Aparicio | Operating Grant | 2018 | 2021 | Susan G. Komen Breast Cancer Foundation | Exploiting new patterns of genome damage in triple negative breast cancer | S Shah | Aparicio S | $600,000 USD |
| Samuel Aparicio | Operating Grant | 2014 | 2022 | Canadian Institutes of Health Research (CIHR) | Integrating Quantitative Imaging Methods and Genomic Biomarkers to Assess the Therapeutic Response of Cancers | F Benard | RD Morin, S Aparicio, A Celler, J Laskin, SP Shah, K Gelmon, J Connors, S Chia, G Hamarneh | $398,605 |
| Samuel Aparicio | Operating Grant | 2015 | 2022 | Canada Research Chairs | Chair in Molecular Oncology (Tier 1) | S Aparicio | $200,000 | |
| Samuel Aparicio | Operating Grant | 2017 | 2022 | Canadian Institutes of Health Research / CEEHRC / Genome BC | Centre for Epigenome Mapping Technologies | M Hirst, M Marra, S Jones | S Aparici, C Eaves, P Lavoie, D Renouf, K Schultz | $890,000 |
| Samuel Aparicio | Infrastructure Grant | 2019 | 2022 | Canada Foundation for Innovation (University of British Columbia, Ontario Institute for Cancer Research, Ontario Research Fund, MESI Programme de Soutien a la recherche volet 3, BC Knowledge Development Fund (BCKDF), Genome Canada) | The Cancer Genome Collaboratory | L Stein | Bader G, Bourque G, Ferretti V, Knoppers BM, Aparicio S, Simpson J, Shah S (collaborator) | $4,995,318 |
| Samuel Aparicio | Operating Grant | 2018 | 2022 | Breast Cancer Research Foundation | Developing predictive biomarkers for genome targeting agents in TNBC, to single cell resolution | S Aparicio | $865,000 USD | |
| Samuel Aparicio | Team Grant | 2019 | 2022 | American Association for Cancer Research International - Canada / Canadian Institutes of Health Research / Canadian Cancer Society / Stand Up To Cancer Canada | Targeting mRNA translation to effectively treat metastatic breast cancer | N Sonenberg and M Pollak | Sorensen P, Nelson B, Aparicio S, Morin G, Gelmon K, Topisirovic I, Miller W, Quail D, del Rincon S, Kleinman C, Mackey J, Eisenhauer E, Postovit L-M | $649,500 |
| Samuel Aparicio | Operating Grant | 2019 | 2022 | Gray Foundation | Development of strategies to track and prevent breast cancer development in BRCA mutation carriers | J Brugge | S Aparicio, D Livingston, A Venkitaraman,D Dillon, S Santagata, S Gambhir | $196,994 USD |
| Samuel Aparicio | Infrastructure Grant | 2021 | 2022 | The University of British Columbia | Molecular and Advanced Pathology Core (MAPcore): a Translational Research Core Platform for UBC | Huntsman D | Schaffer D, Nielsen T, Gilks B, Hoang L, Bashashati A, Anglesio M, Talhouk A, Ng T, Yip S, Sorensen P, Aparicio S, El Naggar A, Thompson E | $160,000 |
| Samuel Aparicio | Operating Grant | 2021 | 2022 | BC Cancer Foundation, The University of British Columbia | Monitoring breast cancer: Bringing single-cell and liquid biopsy analysis to the cloud | Roth A, Aparicio S, Ha G, Hunter N | $133,685 | |
| Samuel Aparicio | Operating Grant | 2016 | 2023 | Canadian Institutes of Health Research | Targeting the dynamics and genomics of clonal evolution in cancer patients | S Aparicio | S Shah, M Marra, C Hansen, P Stirling | $404,780 |
| Samuel Aparicio | Team Grant | 2017 | 2023 | Cancer Research UK | IMAXT, Imaging and Molecular Annotation of Xenografts and Tumors | G Hannon | S Aparicio, B Bodenmiller, E Boyden, J Joyce, X Zhuang, N Walton, O Harris, S Balasubramanian, C Caldas, S Tavare | 1,100,000 GBP |
| Samuel Aparicio | Operating Grant | 2018 | 2023 | Canadian Cancer Society | Decoding clonal dynamics and evolution in breast cancers at single cell resolution: improving diagnostics and expanding treatment approaches | S Aparicio | Shah S, Gelmon K, Chia S, Hirst M, Hansen C | $1,244,500 |
| Samuel Aparicio | Operating Grant | 2018 | 2023 | Canadian Cancer Society | The determinants of drug response in high grade serous ovarian cancer: a single cell population genetics approach | S Shah | Aparicio S, Huntsman D, McAlpine J, Bouchard A | $1,250,000 |
| Samuel Aparicio | Team Grant | 2018 | 2023 | Terry Fox Research Institute (TFRI) | The Terry Fox New Frontiers Program Project Grant in New Vistas on Cancer Biology and Treatment: Conceptual Advancements from the Forme Fruste Project | D Huntsman | Aparicio S, Morin G, Bouchard-Cote A, Shah S, Hirst M, Lee C, Nielsen T, Sorensen PH, Underhill TM, Yip S | $6,012,984 |
| Samuel Aparicio | Operating Grant | 2016 | 2023 | Canadian Institutes of Health Research (CIHR) | Targeted radiopharmaceuticals to improve cancer diagnosis and treatment | F Benard | S Aparicio, A Celler, D Perrin, T Ruth | $204,609 |
| Samuel Aparicio | Operating Grant | 2020 | 2023 | CDMRP (US DOD) | Dissecting the impact of mutational processes on therapeutic response in ovarian cancer | Shah S | Aparicio S, Chi D, Aghajanian C, Weigelt B | $75,000 USD |
| Samuel Aparicio | Infrastructure Grant | 2021 | 2023 | Canada Foundation for Innovation, BC Knowledge Development Fund, BC Cancer, part of the Provincial Health Services Authority | Cancer Single Cell Dynamics Observatory | Aparicio S | Cheung K, Eaves C, Levings M, Marra M, Steidl C, Penninger J, Huntsman D, Lansdorp P, Bouchard-Côté A | $5,992,026 |
| Samuel Aparicio | Operating Grant | 2021 | 2024 | Wellcome Leap | Predicting treatment induced state changes in triple-negative breast cancer | Hannon G, Abraham J, Marioni J | Clatworthy M, Khaled W, Fisher J, Aparicio S | $4,388,520 (USD) |
| Samuel Aparicio | Operating Grant | 2020 | 2025 | National Institutes of Health | Center for Integrated Cellular Analysis | Satija R | Smibert P, Landau D, Shah S, Aparicio S | $493,900 USD |
| Samuel Aparicio | Operating Grant | 2021 | 2026 | BC Cancer Foundation and University of British Columbia | Breast cancer evolution and therapeutics program, Nan and Lorraine Robertson Chair in Breast Cancer Research | S Aparicio | $11,000,000 | |
| Samuel Aparicio | Operating Grant | 2022 | 2026 | Alex’s Lemonade Stand Foundation | Defining and exploiting novel vulnerabilities for the treatment of metastatic osteosarcoma | Sweet-Cordero EA | Sorensen P, Obenauf A, Janeway K, Aparicio S | $1,100,000 (USD) |
| Samuel Aparicio | Operating Grant | 2017 | 2027 | University of British Columbia (UBC) | Distinguished University Scholar | S Aparicio | $220,000 | |
| Shazia Masud | Team Grant | 2020 | Present | Genome BC | Characterizing SARS-CoV 2 antibody response among exposed health care workers (CARE) | M. Morshed | Inna Sekirov Agatha Jassem Shazia Masud | $250,000 |
| Sohrab Shah | Team Grant | 2016 | 2021 | Terry Fox Research Institute (TFRI) | The Terry Fox New Frontiers Program Project Grant, Overcoming treatment failure in lymphoid cancers | J Connors (Nominated PI) M Marra, C Steidl, S Shah, D Scott, A Weng, G Morin, A Mungall, G Slack | $1,500,000 | |
| Sohrab Shah | Team Grant | 2016 | 2021 | Terry Fox Research Institute (TFRI) | Sub-project 1: Co-evolution of malignant cell populations and infiltrating immune cells in B-cell lymphomas. Sub-project of the above | S Shah, A Weng | C Hansen | $255,760 |
| Sohrab Shah | Team Grant | 2018 | 2021 | CFI | The Cancer Genome Collaboratory | L. Stein | Bader G, Bourque G, Ferretti V, Knoppers B, Morris Q, Paul C. B, Shah SP Simpson J, | $1,665,106 |
| Sohrab Shah | Operating Grant | 2019 | 2021 | Magee-Women Research Institute and Foundation | Developing a human in mouse cancer model with a completely humanized stroma | NA | S Shah | $122,839 USD |
| Sohrab Shah | Operating Grant | 2018 | 2021 | LesLois Shaw Foundation | The spatio-temporal determinants of treatment response in newly diagnosed high-grade serous ovarian cancer: a multi-modal prospective study | S Shah | $754,518 USD | |
| Sohrab Shah | Operating Grant | 2020 | 2022 | Ovarian Cancer Research Fund | Profiling co-evolution of ovarian cancer and its immune microenvironment | S Shah | $900,000 USD | |
| Sohrab Shah | Operating Grant | 2018 | 2023 | CCSRI | The determinants of drug response in high grade serous ovarian cancer: a single cell population genetics approach. | S. Shah | S Aparicio, D Huntsman, J McAlpine, A Cote-Bouchard | $250,000 |
| Sohrab Shah | Team Grant | 2018 | 2023 | Cancer Research UK | IMAXT, Imaging and Molecular Annotation of Xenografts and Tumours | G Hannon | S Aparicio, B Bodenmiller, E Boyden, JJoyce, X Zhuang | $865,852 USD |
| Sohrab Shah | Team Grant | 2017 | 2023 | Cancer Research UK | IMAXT, Imaging and Molecular Annotation of Xenografts and Tumours | G Hannon | S Aparicio, B Bodenmiller, E Boyden, JJoyce, X Zhuang | $183,333 GBP |
| Sohrab Shah | Operating Grant | 2018 | 2023 | CCSRI | Molecular Pathogenesis of Clear Cell Carcinoma of the Ovary: Towards Better Prevention and Management Strategies. | D Huntsman | G Morin, Shah SP, C Gilks, T Underhill, Y Wang, D Cochrane, A Talhouk, E Miguel | $399,802 |
| Sohrab Shah | Operating Grant | 2018 | 2023 | CCSRI | Decoding clonal dynamics and evolution in breast cancers at single cell resolution: Improving diagnostic and expanding treatment approaches | S Aparicio | S Shah, K Gelmon, C Hansen, M Hirst | $250,000 |
| Sohrab Shah | Team Grant | 2018 | 2023 | Terry Fox Research Institute (TFRI) | New Vistas on Cancer Biology and Treatment: Conceptual Advancements from the Forme Fruste project | D. Huntsman | UnderHill M., Sorensen P., Morin G., Hirst M., Stirling P., Aparicio S., Shah SP., Bouchard-Cote A., Nielsen T., Yip S., Lee C. | $1,002,164 |
| Sohrab Shah | Under Review | 2020 | 2023 | United States Department of Defence Congressionally Directed Medical Research Programs | Dissecting the impact of mutational processes on therapeutic response in ovarian cancer | S Shah | $768,401 USD | |
| Sohrab Shah | Operating Grant | 2021 | 2024 | Congressionally Directed Medical Research | Integrating tumor genetics and microenvironment as predictors of response and resistance to immunotherapy in ovarian cancer | Powell | Shah | $27,397 |
| Sohrab Shah | Under Review | 2021 | 2024 | V Foundation for Cancer Research | T2021-007 Immunotype Identifies Immune Checkpoint Blockade Responders: Dissecting the mechanism and understanding the scope and impact of immunotype across diverse cancer patient populations. | Callahan | $600,000 | |
| Sohrab Shah | Under Review | 2022 | 2024 | Ovarian Cancer Research Fund | Inferring mutational processes and patient stratification from standard-of-care clinical imaging | S Shah | $900,000 | |
| Sohrab Shah | Under Review | 2021 | 2024 | The V Foundation | #NAME? | Cheung | S Shah | $180,000 |
| Sohrab Shah | Under Review | 2022 | 2024 | Break Through Cancer | Ovarian Cancer (MOD) | Aghajanian | S Shah | $2,000,177 |
| Sohrab Shah | Under Review | 2020 | 2025 | New York Genome Center | Center for Integrated Cellular Analysis | R Satijia | S Shah | $493,900 USD |
| Sohrab Shah | Operating Grant | 2021 | 2026 | National Cancer Institute | U24 CA264028-01 The MSK Genomic Data Analysis Center for Tumor Evolution | S Shah/ Shultz | $ 2,124,000 USD | |
| Stephen Yip | Team Grant | 2016 | 2021 | National Medical Research Council TCR Flagship - Ministry of Health, Singapore | Targeting Brain Tumors: Improving lives through Precision Medicine | Ang Beng Ti | Theme PI & Co-PI: Patrick Tan (Duke-NUS); Chang Young-Tae (NUS); Carol Tang (NNI); Tan Nguan Soon (NTU); Huang Zhi Wei (NUS); Shao Huilin (IMCB, A*STAR); Ng Wai Hoe (NNI); Nicolas Kon (NNI). Collaborations - Ivy Ho (NNI); Brian Toyota (VGH & UBC); Stephen Yip (VGH / BCCA) | 65,000.00 |
| Stephen Yip | Operating Grant | 2019 | 2021 | Canada's Digital Technology Supercluster (CDTS) – UBC | UBC Digital Pathology Project | Marco Marra Stephen Yip Steve Jones | $211,537 | |
| Stephen Yip | Team Grant | 2018 | 2024 | Terry Fox Research Institute | New Vistas on Cancer Biology and Treatment: Conceptual Advancements from the Forme Fruste Project | Huntsman D (leader), Underhill M, Sorenson P, Morin G, Hirst M, Stirling P, Aparicio S, Shah S, Bouchard-Cote, Nielsen T, Yip S (Clinical core and Project 2) | $6,000,000 | |
| Susan Porter | Operating Grant | 2019 | 2021 | UBC SIF | Postdoc Career In-Sites Project | H. Khanlian | S. Porter (sponsor) | $67,650 |
| Susan Porter | Operating Grant | 2019 | 2021 | UBC SIF | Enhancing Graduate Student Community | S. Porter | GSS, VP--Students | $140,000 |
| Susan Porter | Operating Grant | 2019 | 2021 | UBC Strategic Investment Fund (SIF) | Supporting Aboriginal Graduate Enhancement (SAGE) Across the Insitution | J. Hare | S. Porter (sponsor) | $76,000 |
| Suzanne Vercauteren | Operating Grant | 2019 | 2021 | BC Children's Hospital Research Institute | Multimedia e-consenting platform for biobanking and other research | Suzanne Vercauteren | H. Longstaff, E. Portales-Casamar, J. Robillard, A. Virani | 25,000 |
| Suzanne Vercauteren | Operating Grant | 2019 | 2021 | Terry Fox Research Institute | PRecision Oncology For Young peopLE (PROFYLE) | Philipp Lange | Suzanne Vercauteren | 164,226 |
| Suzanne Vercauteren | Operating Grant | 2019 | 2022 | Canadian Institutes of Health Research | Folic acid supplementation in children with sickle cell disease: A double-blind randomized crossover trial | Karakochuk, Crystal D | Devlin, Angela M; Lamers, Yvonne; Vercauteren, Suzanne M; Williams, Brock A; Wu, John K | 180,000 |
| Suzanne Vercauteren | Operating Grant | 2020 | 2022 | Canadian Donation and Transplantation Research Program (CDTRP) | Evaluating the Heterogeneity of T Cell Phenotypes in Pediatric Renal Transplant Recipients: Associations with Stable and Rejection Histology, and Additional Markers of Alloimmune Activity | Suzanne Vercauteren | Li Wang; Megan Levings; Michael Irvine; Samantha Lang; Shirin Kalyan; Tom Blydt-Hansen | 30,000 |
| Suzanne Vercauteren | Operating Grant | 2020 | 2022 | BC Children's Hospital Research Institute | Evaluating the Heterogeneity of T Cell Phenotypes in Pediatric Renal Transplant Recipients: Associations with Patient and Transplant Factors, and Alloimmune Activity | Tom Blydt-Hansen | Suzanne Vercauteren | 30,000 |
| Suzanne Vercauteren | Team Grant | 2018 | 2023 | CIHR | Canadian Autoimmunity Standardization Core (CAN-ASC) | Megan Levings | 500,000 | |
| Suzanne Vercauteren | Operating Grant | 2021 | 2023 | BC Children's Hospital Research Institute | Enhancing MRD-based Risk Stratification for Childhood Leukemia | Gregor Reid | Ramon Klein Geltink, Suzanne Vercauteren | 30,000 |
| Suzanne Vercauteren | Operating Grant | 2021 | 2023 | BC Children's Hospital Research Institute | Single Cell Profiling of Hematopoietic Stem and Progenitor Cells in Pediatric Aplastic Anemia | Suzanne Vercauteren | Derek Chan, aly Karsan, Wyeth Wasserman | 30,000 |
| Suzanne Vercauteren | Operating Grant | 2020 | 2025 | CIHR | Canadian Collaboration for Child Health: Efficiency and Excellence in the Ethics Review of Research (CHEER) | Carpentier, Richard; Lacaze-Moasmonteil, Thierry; Marlin, Susan | 2,491,470 | |
| Tanya Nelson | Other (development grants) Grant | 2020 | 2023 | Genome Canada/Genome BC | Implementation of Diagnostic Whole Genome Sequencing for Rare Diseases in British Columbia | Anna Lehman | Pam Ramsay, Tanya Nelson, Linlea Armstrong, Suzanne Vercauteren | $3M |
| Tanya Nelson | Other (development grants) Grant | 2021 | Present | BCCHRI | Clinical Validation of Next Generation Sequencing”, | Tanya Nelson | Lindsay Brown, Christine Tyson, Bradley Coe, Allison Matthews | $25K |
| Tanya Nelson | Other (development grants) Grant | 2021 | Present | Dr. Donald B. Rix Pathology & Laboratory Medicine Research Grant | Assessing the feasibility of implementing non-invasive genetic diagnosis (NIPD) in the Division of Genome Diagnostics | Lindsay Brown | Nelson, Tanya; Strong, Emma ; Tyson, Christine; Bretherick, Karla; Langlois, Sylvie; Vallance, Hilary; Seath, Kimberly | $49,862 |
| Terry Jefferson | Operating Grant | 2019 | 2021 | BC Children's Hospital | Assessment of Colonic Serotonin Metabolism in SIDS | Jefferson Terry | $15,000 | |
| Tony Ng | Operating Grant | 2018 | 2023 | Canadian Cancer Society Research Institute (CCSRI) | Adolescent & young adult sarcomas: translating basic science into clinical care – CCSRI Impact Grant | T. Nielsen | 1250000 | |
| Torsten Nielsen | Operating Grant | 2018 | 2022 | CIHR | DCIS-Precise: A Genomics-Driven Model for Predicting DCIS Response to Radiation | Eileen Rakovitch (Sunnybrook) | MT Hallett T Nielsen +7 others | 910352 |
| Torsten Nielsen | Operating Grant | 2018 | 2023 | Canadian Cancer Society (Impact Grant Program) | Adolescent & young adult sarcomas: translating basic science into clinical care | Torsten Nielsen | TM Underhill M Hirst TL Ng TA Alcindor | 1.25 million |
| Torsten Nielsen | Team Grant | 2018 | 2023 | NIH (USA) U54 Program Project | Targeting SS18-SSX biology in synovial sarcomagenesis | Kevin B Jones (Utah) | TO Nielsen, TM Underhill. , M Ladanyi, S Lowe, A Banito, B Cairns | USD 8.5 million |
| Torsten Nielsen | Infrastructure Grant | 2020 | 2023 | UBC Strategic Investment Fund | Molecular and Advanced Pathology Core | David Huntsman | Torsten Nielsen David Schaeffer | 160000 |
| Torsten Nielsen | Equipment Grant | 2019 | 2024 | Canada Foundation for Innovation | The Molecular Path: Connecting Biologic Insights To Improve Cancer Outcomes | Torsten Nielsen | David Huntsman, David Schaeffer | $2 million |
| Torsten Nielsen | Operating Grant | 2020 | 2024 | Canadian Cancer Society | Clinical application of a targeted proteomic classifier for triple negative breast cancer | Gregg Morin | Torsten Nielsen | 449939 |
| Torsten Nielsen | Operating Grant | 2016 | 2025 | CIHR | Randomized Trial of Regional Radiotherapy in Luminal A Breast Cancer | Tim Whelan (McMaster) | T.O. Nielsen + 17 others | 4.9 million |
| Torsten Nielsen | Team Grant | 2018 | 2025 | Terry Fox Research Institute | The Terry Fox New Frontiers Program in new vistas on cancer biology and treatment | D Huntsman | T Nielsen, S Aparicio, S Shah, G Morin, TM Underhill, PH Sorensen, M Hirst, P Stirling, S Yip | 6 million |
| Torsten Nielsen | Group Grant | 2021 | Present | Terry Fox Foundation / CIHR Marathon of Hope Cancer Centres Network | Enabling Precision Oncology of Sarcomas in Canada | Torsten Nielsen | Martin Hirst | 504000 |
| Valery Lavergne | Operating Grant | 2016 | 2021 | Wright Medical Technology (Arlington, TN) Research and Developement | Prophylactic Antibiotics against Propionibacterium acnes in shoulder surgery: A Randomized Controlled Trial | Dominique Rouleau | Valery Lavergne | 50,000 |
| Veronica Hirsch-Reinshagen | Operating Grant | 2020 | 2021 | Faculty of Medicine, University of British Columbia | New Faculty Research Award | V. Hirsch-Reinshagen | 10,000 | |
| Veronica Hirsch-Reinshagen | Operating Grant | 2020 | 2021 | Rick Hansen Foundation | Advanced MRI techniques to measure spinal cord microstructure in vivo: development, reproducibility and application to SCI | C. Laule | B. Kwon, P. Kozlowski, W. Moore, V. Hirsch-Reinshagen, M. Heran, E. Sayre, A. Yung | 20,000 |
| Veronica Hirsch-Reinshagen | Operating Grant | 2020 | 2021 | Rick Hansen Foundation | Characterizing autoantibodies in human traumatic spinal cord injury | V Hirsch-Reinshagen | B Kwon, M Nimmo | 20,000 |
| Veronica Hirsch-Reinshagen | Operating Grant | 2017 | 2022 | Canadian Institutes of Health Research | The Canadian ADNI Brain Donation and Neuropathology Network (CABIN) | IR Mackenzie | HM Chertkow, G-YR Hsiung, LC Ang, S Black, M Borrie, E Finger, M-C Guiot, V Hirsch-Reinshagen, J Keith. | 1,065,000 |
| Veronica Hirsch-Reinshagen | Operating Grant | 2020 | 2023 | Canadian Institutes of Health Research | Delineating between pathophysiologic phenotypes of hypoxic ischemic brain injury after cardiac arrest | M. Sekhon | P. Ainslie, D. Griesdale, V. Hirsch Reinshagen, R. Hoiland, W. Panenka, C. Wellington | 447,526 |
| Victor Leung | Operating Grant | 2019 | 2024 | Canadian Institutes of Health Research | Fecal microbiota transplantation (FMT) for intestinal decolonization of multidrug-resistant opportunistic pathogens | Amee R. Manges | Victor Leung, Jennifer Grant, Alissa Wright, Ted Steiner | $566,100 |
| Victor Ling | Operating Grant | 2018 | 2022 | Terry Fox Research Institute | The role of tetrahydroxylated bile acids (THBAs) in preventing liver cancer and other GI diseases | Victor Ling | 200,000 | |
| Vijay Gadkar | Operating Grant | 2020 | 2021 | Peter Wall Institute for Advanced Studies | Swab-to-PCR: Simple and Rapid Diagnosis of COVID-19 Using Extraction-Free Nucleic Acid Amplification | Peter Tilley | Vijay Gadkar, David Goldfarb; Ghada Al-Rawahi; Jocelyn Srigley; Linda Hoang | 19,624 |
| Vijay Gadkar | Operating Grant | 2020 | 2022 | BC Children's Hospital Healthy Starts | Rapid Diagnosis of Viral Infections in Children by Metagenomic Nanopore Sequencing | Peter Tilley | Vijay J. Gadkar, David Goldfarb | 38,878 |
| Vilte Barakauskas | Operating Grant | 2020 | 2021 | BC Children's Hospital Research Institute, Childhood Diseases Seed Grant | Project: Planning PRISM2 - Pilot work to establish Pediatric Reference Intervals for Safe Medicine, focusing on neonates first | Kate Chipperfield | Co-applicant: Vilte Barakauskas; Co-investigators: Horacio Osiovich, John Wu, Nick Au, Robert Everett, Suzanne Vercauteren | $30,000 CAD |
| Vilte Barakauskas | Operating Grant | 2017 | 2021 | Canadian Institutes of Health Research (CIHR) Operating Grant for Data Anaysis Using Existing Databases | Mining the gap: Establishment of pregnancy-specific laboratory reference intervals using provincial laboratory data | Vilte Barakauskas | Co-applicants: Benjamin Jung, Khosrow Adeli, Li Wang, Wee-Shian Chan Collaborators: Hilary Vallance, Kent Dooley | $68,230 CAD |
| Vilte Barakauskas | Operating Grant | 2020 | 2022 | BCCHR Clinical Translational Research Seed Grant | Leveraging laboratory and provincial databases to improve assessment of thyroid hormone testing in pregnancy. | Vilte Barakauskas | Amelie Boutin | $10,000 |
| Vincenzo Giambra | Operating Grant | 2016 | 2021 | Canadian Institutes of Health Research (CIHR) | Mediators and targets of Wnt signaling in T-ALL stem cells | Vincenzo Giambra | 850,951 (CAD) | |
| Vincenzo Giambra | Operating Grant | 2021 | Present | Messengers of Knowledge Grant. Italian Ministry of Education, University and Research (MIUR) federal funding | Analytical methods for the identification and characterization of cancer stem cells | Vincenzo Giambra | 36,600 (Euros) | |
| Wan Lam | Operating Grant | 2016 | 2021 | NIH | Using 'Omics to Build an Atlas of Placental Development and Function Across Pregnancy | Wendy Robinson | Alphabetically: Sue Kildea, Gerlinde Metz, David Olson, Elodie Portales-Casamar, Cathy Vaillancourt, Alex Beristain, Suzanne King, Wan Lam, Jane Ng, Tim Oberlander, Maria Penaherrera | $1,412,785 (US) |
| Wan Lam | Operating Grant | 2019 | 2021 | Cancer Research Society (CRS) | The Role of LRRK2 in Lung Cancer | Sharon Gorski | Wan Lam | $120,000 |
| Wan Lam | Operating Grant | 2015 | 2022 | CIHR Foundation Scheme | An Integrative Approach to Understand Lung Cancer Development in Smokers and Non-smokers Carcinogenesis | Wan Lam | $2,631,735 | |
| Wan Lam | Group Grant | 2021 | 2028 | BC Cancer Foundation | PRO-Lung: Prevention and Research to Improve Outcomes for Lung Cancer, Platform II: Biology and Preclinical Therapeutics | Will Lockwood and Wan Lam | $2,940,000 | |
| Wan Lam | Group Grant | 2021 | 2028 | BC Cancer Foundation | PRO-Lung: Prevention and Research to Improve Outcomes for Lung Cancer, Core II: Single Cell Phenomics and Computation Biology | Calum MacAulay and Wan Lam | $2,125,000 | |
| William Lockwood | Operating Grant | 2016 | 2021 | Canadian Institutes for Health Research (CIHR), Project Grant | Developing agonistic therapeutic strategies for lung cancer based on synthetic lethal oncogene interactions | William Lockwood | Sidong Huang, Gregg Morin | $764,500 |
| William Lockwood | Equipment Grant | 2014 | 2021 | British Columbia Cancer Agency Investigator Establishment Fund | Integrating Clinical, Functional and Chemical Genomics to Understand Lung Cancer Biology | William Lockwood | $300,000 | |
| William Lockwood | Operating Grant | 2014 | 2021 | British Columbia Cancer Agency Lung Cancer Research Program Start-Up Costs | Integrating Clinical, Functional and Chemical Genomics to Understand Lung Cancer Biology | William Lockwood | $900,000 | |
| William Lockwood | Salary Support | 2016 | 2021 | Canadian Institutes for Health Research (CIHR), New Investigator Award | Integrating Clinical, Functional and Chemical Genomics to Understand Lung Cancer Biology | William Lockwood | $300,000 | |
| William Lockwood | Operating Grant | 2019 | 2021 | British Columbia Lung Association | Defining mechanisms of lineage transformation in lung adenocarcinoma to combat resistance to targeted therapies | William Lockwood | Yusuke Inoue | $50,000 |
| William Lockwood | Operating Grant | 2020 | 2022 | Lung Cancer Research Foundation | SNF2 Histone Linker PHD RING Helicase as a novel tumor suppressor gene and risk factor in lung adenocarcinoma development | William Lockwood | $150,000 (USD) | |
| William Lockwood | Operating Grant | 2020 | 2023 | Canadian Institutes of Health Research | The effects of smoking marijuana on lung cancer development: implications for screening and early detection. | William Lockwood | Peter Stirling | $688,500 |
| William Lockwood | Operating Grant | 2021 | 2023 | Cancer Research Society | Managing EGFR inhibitor resistance in lung adenocarcinoma through drug holiday induced hyperactivation of oncogenic pathways | William Lockwood | $120,000 | |
| William Lockwood | Operating Grant | 2021 | 2026 | Canadian Institutes of Health Research (CIHR) | Understanding the effects of ERK hyperactivation in cancer: implications for therapy | William Lockwood | $956,250 | |
| William Lockwood | Group Grant | 2021 | 2026 | BC Cancer Foundation | PRO-Lung Platform II: Biology and Preclinical Therapeutics | William Lockwood & Wan Lam | $2,940,000 | |
| William Godolphin | Other (education innovation) Grant | 2020 | 2021 | UBC Equity Enhancement Fund | Students learning from patients: increasing diversity and inclusion | A Towle | W Godolphin, C Kline | $10,000 |
| William Godolphin | Other (education innovation) Grant | 2021 | 2023 | Royal College/Associated Medical Services CanMEDS Research Development Grant | Bringing Patients and Society Back into the Social Accountability of a Medical School | A Towle | C Canfield, C Cuncic, W Godolphin, C Holmes, M Hubinette, C Kline, D Lauscher, S Macdonald | $24,855 |
| William Hsiao | Operating Grant | 2019 | 2021 | Genome British Columbia | Unified Pathogen Control OneHealth Approach Specifically Targeting Norovirus (UPCOAST-N), | Natalie Prystajecky | Paul Levett, William Hsiao, | 499,990 |
| William Hsiao | Operating Grant | 2019 | 2021 | Genome British Columbia | One Health” Syst-Omics approach to reduce Campylobacter in agri-food chain | Xiaonan Lu | William Hsiao | 500,000 |
| William Hsiao | Operating Grant | 2019 | 2021 | Genome British Columbia | Unified Pathogen Control Onehealth Approach Specifically Targeting Vibrio (UPCOAST-V), Grant, | Katie Eloranta; Linda Hoang | William Hsiao | 500,000 |
| William Hsiao | Operating Grant | 2018 | 2021 | Genome Canada | Bioinformatics Tools to Enable Federated, Real Time Genomic Epidemiology Data Sharing and Analysis in a One Health Framework, Grant | William Hsiao | Gary Van Domselaar | 1,164,488 |
| William Hsiao | Operating Grant | 2018 | 2021 | Canadian Institutes of Health Research (CIHR) | Bioinformatics Tools to Improve Data Sharing and Re-use in Public Health - applications in antimicrobial resistance profiling and source tracking, | William Hsiao | Andrew McArthur; Damion Dooley; Emma Griffiths; Fiona Brinkman; Inna Sekirov; Morag Graham | 596,700 |
| William Hsiao | Other (development grants) Grant | 2019 | 2021 | CIHR | Technology, Policy and Implementation: a cross-disciplinary workshop to generate innovative solutions for data sharing in public health genomic epeidemiology practice | William Hsiao | 25,000 | |
| William Hsiao | Team Grant | 2018 | 2022 | Canadian Institutes of Health Research (CIHR) | Common Infrastructure for National Cohorts in Europe, Canada, and Africa (CINECA), | Fiona Brinkman | William Hsiao, Guillaume Bourque; Michael Brudno | 800,000 |
| William Hsiao | Team Grant | 2018 | 2023 | Canadian Institutes of Health Research (CIHR) Canadian Microbiome Initiative 2: Research Core | Integrated Microbiome Platforms for Advancing Causation Testing and Translation (IMPACTT), Grant | Kathy McCoy | William Hsiao, Paul Kubes, Philippe Gros, Anita Kozyrskyj, Marie-Claire Arrieta, Karen Madsen, Joe Harrison, Kaura Sycuro, Ian Lewis, Celia Greenwood, Fiona Brinkman, Markus Geuking, Braedon McDonald, Jayne Danska, Deigo Silva | 3,000,000 |
| Yemin Wang | Operating Grant | 2019 | 2021 | Carraresi Foundation and the Sumiko Kobayashi Marks Memorial OVCARE Research Grants supported by the VGH & UBC Hospital Foundation | Identify molecular alterations predisposing Lynch Syndrome patients to endometrial cancer development. | Yemin Wang | $20,000 | |
| Yemin Wang | Operating Grant | 2021 | 2023 | Canadian Research Society | Developing optimal treatment combinations for small cell carcinoma of the ovary | Sidong Huang | Yemin Wang | $225,000 |
| Yemin Wang | Operating Grant | 2018 | 2023 | Canadian Cancer Society (Impact grant, #705647) | Molecular pathogenesis of clear cell carcinoma of the ovary: towards better prevention and management strategies | David Huntsman | $1, 249,013 | |
| Yemin Wang | Operating Grant | 2021 | 2025 | Canadian Institute of Health Research | Exploit the metabolic vulnerabilities in SWI/SNF-deficient cancer | Yemin Wang | $688,501 | |
| Ying Wang | Operating Grant | 2019 | 2021 | Leducq Junior Investigator Research and Travel Fund. Leducq Foundation "PlaqOmics" Group | Identifying somatic mutations/epigenetic modifications in vascular smooth muscle cell subpopulations and their relationship to plaque composition and phenotype | Ying Wang | $86,500 | |
| Ying Wang | Operating Grant | 2019 | 2021 | Seed Grant, Stanford Cardiovascular Institute | Identify 'Atherogenic' Somatic Mutations/Epigenetic Modifications in Vascular Smooth Muscle Cells | Ying Wang | $20,000 | |
| Ying Wang | Team Grant | 2021 | Present | Leducq Foundation | Highlighting the biological relevance of somatic mutations in lesion infiltrating leukocytes and smooth muscle cells in atherogenesis | Ying Wang Moritz von Scheidt | Saikat Ghosh Michal Mokry Chani Hodonsky Hua Gao Kenji Kawai Atsushi Sakamoto | 174900 |
| Ying Wang | Operating Grant | 2021 | Present | UBC Faculty of Medicine New Faculty Research Award | Targeting efferocytosis to reduce risk of cardiovascular events | Ying Wang | 10000 | |
| Yongjin Park | Infrastructure Grant | 2022 | 2022 | Cascadia Collaboration Award | Eavesdropping communications between cancer and immune cells | Yongjin Park (BCCRC/UBC) | Ramon Klein Geltink (BCCHR/UBC), Samuel Aparicio (BCCRC/UBC) | 168,201 (USD, cloud computing credit) |
| Zhou Chen | Operating Grant | 2018 | 2022 | BC Cancer Foundation | Predictors of immunotherapy for non-small cell lung cancer | Chen Zhou | 25,000 | |
| Zu-Hua Gao | Operating Grant | 2020 | 2021 | The Canadian Institutes of Health Research | Matricellular protein CCN5/WISP2 mediates a synergistic stimulation of pancreatic beta-cell expansion by IGF-I and Wnt signaling | Zu-Hua Gao, et al. | $100,000 (10% time) | |
| Zu-Hua Gao | Operating Grant | 2020 | 2024 | The Canadian Institutes of Health Research | Developing retinal gene augmentation therapy for Zellweger Spectrum Disorder | Nancy E. Braverman | Zu-Hua Gao, et al. | $933,000 (10% time) |
| Zuzana Kos | Training Grant | 2021 | Present | University of Ottawa Dutkevich Summer Student Award | Funding for Medical Student (Tadros Attala) for Summer Research Project | Dr. Zuzana Kos | Dr. Sarah Strickland | $3,500 |